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Regulation of Medical Waste in the
United States
LAURA CARLAN BATTLE*
When wash-ups of syringes and medical vials closed north-
eastern beaches, public outcry galvanized Congress to pass
the Medical Waste Treatment Act (MWTA). Congress di-
rected the U.S. EPA to investigate whether medical waste
should be treated as hazardous or solid waste, and whether
a federal regulatory scheme is warranted. In the following
article, the author explores varied laws and policies gov-
erning the treatment, handling and disposal of medical
waste in the United States, the ongoing debate about risks
associated with exposure to medical waste, and the ramifi-
cations of our current fragmented regulatory approach.
I. Introduction
Rising health care costs are focusing national attention
on the health care industry. With the proposed national
health care insurance plan under construction, our health
care system is being scrutinized in order to ascertain why
medical costs continue growing so rapidly. One overlooked
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Wake Forest University School of Law, 1984; M.A., Journalism, Regent Univer-
sity, 1980; B.A., Journalism, University of Georgia, 1978. The author has
served as both a United States Navy and Air Force Judge Advocate, and is cur-
rently assigned to the United States Air Force Environmental Law and Litiga-
tion Division in Arlington, Virginia.
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component of burgeoning medical costs is medical waste
management. A realistic analysis of present and future
health care costs must consider the growing amount of medi-
cal waste and the concomitant increase in its regulation. The
problems associated with medical waste management are not
unique to the United States.1
The total amount of medical waste generated in the
United States today is difficult to ascertain. Differences in
the definition and tracking procedures for medical waste used
by different groups, as well as the difficulty in determining
the amount of home health care waste which is generated,
contribute to this general uncertainty.2 Most estimates, how-
ever, indicate that the volume of medical waste is relatively
small when compared to the total municipal solid waste
stream.3 In 1990, for example, the Environmental Protection
Agency (EPA) estimated that approximately 500,000 tons of
medical waste are produced annually in the United States by
regulated generators, such as hospitals and medical offices.
This represents 0.3 percent (by weight) of 158,000,000 tons of
municipal solid waste originating from all sources. 4 Infec-
1. In 1992 French and German police discovered an illegal waste dumping
network that had transported and dumped in France an estimated 500 tons of
medical waste including syringes, empty plastic blood bags and catheters gen-
erated in East German hospitals. The European Commission is writing a waste
directive requiring members to dispose of waste at a location as close as possi-
ble to the place of generation. Tara Patel, German Syringes Turn up in French
Quarry, NEW SCIENTIST, Aug. 22, 1992, at 7. By comparison, the problem of
illegal medical waste disposal in Britain has prompted passage of the National
Health Service and Community Care Act of 1990 which removed hospitals'
"crown immunity" in 1991, thereby rendering hospital managers and the chief
executives of health facilities subject to environmental regulation and personal
liability for violations. Oliver Tickell & Alan Watson, Hospital Waste: A Case
for Treatment, NEW SCIENTIST, Mar. 28, 1992, at 34-35.
2. U.S. CONG. OFFICE OF TECHNOLOGY ASSESSMENT, ISSUES IN MEDICAL
WASTE MANAGEMENT: BACKGROUND PAPER 3-4 (1988) [hereinafter OTA BACK-
GROUND PAPER].
3. OFFICE OF TECHNOLOGY ASSESSMENT, FINDING THE RX FOR MANAGING
MEDICAL WASTES (1990) [hereinafter OTA REPORT].
4. OFFICE OF SOLID WASTE, ENVIRONMENTAL PROTECTION AGENCY, MEDI-
CAL WASTE MANAGEMENT IN THE UNITED STATES, FIRST INTERIM REPORT TO CON-
GRESS 1-3 (1990) [hereinafter EPA FIRST INTERIM REPORT]. A briefing document
prepared for Congress in 1993 raised the estimate of municipal solid waste gen-
erated annually in the United States to 180,000,000 tons. ENVIRONMENTAL AND
2http://digitalcommons.pace.edu/pelr/vol11/iss2/2
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tious medical wastes are believed to represent approximately
15 percent of total regulated medical wastes, although this
figure can also vary widely due to differences in definitions,
treatments, and disposal practices utilized at different medi-
cal facilities. 5
As the amount of medical waste increases, so does the
need for lawful and affordable disposal options.6 Further-
more, as the demand for medical waste treatment and dispo-
sal services grows, so does the cost of managing this waste.7
While many generators install incineration units as the most
convenient and efficient method of disposal, many hospitals
ENERGY STUDY INSTITUTE, BRIEFING BOOK 55 (1993) [hereinafter EESI BRIEFING
BOOK].
5. OTA BACKGROUND PAPER, supra note 2, at 4. For purposes of this pa-
per, infectious waste shall be assumed to be a subset of the more inclusive term
"medical waste." "Sharps" include hypodermic needles, syringes, scalpel blades,
etc. See 42 U.S.C. § 6992a(a)(4) (1983 & Supp. 1992).
6. The medical waste industry estimates the prospective size of the mar-
ket to be between $500,000,000 and $1,000,000,000 annually. Some predict
that as these figures escalate and more regulations develop, more medical
waste generators will suffer severe financial impacts from managing their med-
ical waste. Janet Emmerman, A Prescription for Cleaning Up Medical Waste,
USA TODAY MAGAZINE, May 1991, at 78, 79. However, the National Solid
Waste Management Association (NSWMA) cites that in the past four years
competitive pressures have actually driven prices down. Prices are expected to
again rise with new regulations, competitive fallout and consolidation of compa-
nies trying to hold their market. The $500-million-per-year market today is
projected to climb to a $1.5-billion-per-year business by 2000. Michael Malloy,
Medical Waste Treatment: A Status Report, WASTE AGE, Aug. 22, 1992, at 66;
Telephone interview with Tom Goldberg, Director, Medical Waste Institute,
NSWMA, Washington, D.C. (July 1993).
7. See William Marbach, Nuking Nasty Medical Waste-In a Microwave,
Bus. WK., Jul. 23, 1990, at 68. One industry association predicts that the
United States Occupational Safety and Health Administration's (OSHA) recent
bloodborne pathogen standard and the Department of Transportation's (DOT)
newest rule affecting medical waste transporters will also drive costs up. Mal-
loy, supra note 6, at 68. The American Hospital Association (AHA) projected
earlier that increased regulation could inflate the typical hospital medical
waste disposal budget by $200,000. Jennifer Carlile, Finding Disposal Options
for Medical Waste, Am. CITY & CoUNTY, Nov. 1989, at 66, 76. See also LESLIE
ANDERSON MORALES, MANAGING MEDICAL WASTES: A BIBLIOGRAPHY OF PERIODI-
CAL LITERATURE, 1987-1989 (1990), in which the author notes that where on-
site disposal is not possible, finding off-site disposal locations may be difficult,
and that generally the greater the distance from point of collection to point of
disposal, the higher the cost. Rising costs are exacerbated by dwindling landfill
space. Id.
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are reluctant to make such a large capital investment in a
non-patient care item.8 Consequently, many medical waste
generators may reduce short term costs by relying on com-
mercial transporter and off-site disposal services, while si-
multaneously increasing their potential exposure to liability.9
These costs of medical waste management can have a direct
impact on patient care costs. 10
The growing amount of medical waste generated contrib-
utes to rising medical waste management costs." Estimates
on the amount of medical waste generated vary significantly
depending on the data source and the way medical waste is
defined. A broader definition of "infectious" naturally encom-
passes more types of waste and affects disposal options. In
addition, growth of the waste stream is a product of our in-
creasing population and affluence, the greater accessibility of
medical treatment nationwide, and the health care industry's
increased use of disposable products.12 In the past five years,
both federal and state regulation of medical waste has in-
creased, which has consequently made more waste suscepti-
ble to special treatment and increased costs. 13 While such
regulated medical waste does not generally include hazard-
ous or radioactive materials, the volume is also growing be-
cause concern regarding transmission of AIDS prompts
8. Emmerman, supra note 6, at 78. In addition, forthcoming EPA regula-
tions on incineration and the growing number of state regulations are expected
to make incineration a less attractive and less economical disposal method.
Debra K. Rubin, et al., Medical Market Gets Infectious, ENR, Jan. 7, 1991, 26,
26-27.
9. Malloy, supra note 6, at 73. Liability for improper handling and dispo-
sal most often attaches under the Resource Conservation Recovery Act (RCRA),
42 U.S.C. §§ 6901-6992k (1983 & Supp. 1992), and under the Comprehensive
Environmental Response, Compensation, and Liability Act (CERCLA), 42
U.S.C. §§ 9601-9675 (1983 & Supp. 1992).
10. Suzan Onel, The Medical Waste Tracking Act of 1988: Will It Protect
Our Beaches?, 9 VA. ENVTL. L.J. 225, 230-31 (1989).
11. OFFICE OF PUBLIC AFFAIRS, U.S. ENVIRONMENTAL PROTECTION AGENCY,
ENVIRONMENTAL BACKGROUNDER: MEDICAL WASTE 1 (1989). See also Kate Bal-
len, Zapping Waste, FORTUNE, Nov. 5, 1990, at 18.
12. See OTA REPORT, supra note 3, at 22, concerning increasing use of dis-
posable health care products.
13. See generally OTA REPORT, supra note 3.
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hospitals and other medical facilities to use more disposables
and to classify more waste as infectious. 14
Governmental regulation of medical waste in the United
States is fragmented and uncoordinated. A patchwork of fed-
eral and state statutes, regulations, standards and guidelines
currently govern the generation, handling, transportation
and disposal of medical waste. This paper comparatively
analyzes the major sources of regulation of medical waste in
the United States, including federal statutes, state statutes
and regulations, nonbinding federal guidelines, work practice
standards, and hospital accreditation standards. It also ex-
amines the ongoing public and scientific debate concerning
the risk medical waste mismanagement poses to human
health and the environment. This debate has significantly
affected EPA and state approaches to medical waste regula-
tion, and it continues to shape policy regarding medical waste
management in the United States. Finally, this article con-
cludes that minimum federal standards are needed to ensure
a uniform definition of medical waste and consistency in state
regulation of medical waste management.
II. Characterization and Definition of the Medical
Waste Stream
A. Historical Background
Medical waste was first formally recognized as a distinct
waste stream by a federal agency in 1978 when EPA consid-
ered classifying infectious waste as hazardous waste under
the Resource Conservation Recovery Act (RCRA).15 In fact,
when EPA first proposed hazardous waste regulations, infec-
tious wastes were included.' 6 However, in 1979, the agency
determined that infectious wastes did not pose a significant
health threat, and when EPA promulgated its RCRA hazard-
ous waste regulations in 1980, it chose not to classify infec-
14. Rubin et al., supra note 8, at 26.
15. OTA BACKGROUND PAPER, supra note 2, at 6.
16. Id.
1994]
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tious waste as hazardous. 17 This is unusual because the
language of RCRA specifically includes "infectious" as a char-
acteristic to be considered in determining whether or not a
waste is hazardous.' 8 The statutory language can be inter-
preted as requiring these wastes to be classified as hazardous
and thus regulated under Subtitle C of RCRA. However,
EPA decided to treat medical waste as solid waste and the
agency never issued the proposed regulations.19
By the end of summer 1988, following notorious beach
wash-ups of medical waste, EPA had changed its position on
the threat of medical waste to one supporting medical waste
regulation.20 Soon thereafter, Congress passed the Medical
Waste Tracking Act (MWTA), 21 adding a demonstration pro-
gram (Subtitle J) to RCRA, and EPA promulgated imple-
menting regulations.22 Even so, in the intervening years
since passage of the MWTA, EPA has produced no significant
research to substantiate a lack of substantial present or po-
tential hazard to human health or the environment when a
waste with infectious characteristics is improperly managed.
EPA has also not issued any assessments based on epidemio-
logical studies of the degree of risk posed by infectious or
other types of medical waste. 23
Consequently, confusion and inconsistency persists re-
garding medical waste policy, since no existing federal regu-
lations comprehensively address the handling,
17. See also NELSON A. ROCKEFELLER INST. OF GOV'T, PERSPECTIVES ON
MEDICAL WASTE: A REPORT, 1-2 (1989) [hereinafter PERSPECTIVES ON MEDICAL
WASTE].
18. See 42 U.S.C. § 6903(5) (1988).
19. OTA BACKGROUND PAPER, supra note 2, at 6 n.14.
20. PERSPECTIVES ON MEDICAL WASTE, supra note 17, at 2.
21. 42 U.S.C. §§ 6992-6992k (1988).
22. 40 C.F.R. § 259 (1988).
23. OTA BACKGROUND PAPER, supra note 2, at 7. EPA is expected to release
a qualitative health assessment in its third and final report to Congress re-
quired under the MWTA. The report was due to be released in September 1991
following expiration of the MWTA demonstration program in June 1991, but it
has not been issued and EPA does not know when it will come out. Telephone
Interview with Ann Coggington, Environmental Protection Specialist, Charac-
terization and Assessment Division, Regulatory Development Branch, EPA Of-
fice of Solid Waste (June 1993).
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transportation, treatment and disposal of medical waste.24
The major area of inconsistency is in the classification or defi-
nition of medical waste, which has broad ramifications be-
cause it dictates the universe of substances subject to an
overlapping array of transportation, labor, environmental,
and safety regulations.
B. Defining Infectious Medical Waste
State and federal regulators do not consistently define
"medical waste" or its subset "infectious waste." Different
terms such as "hospital waste,"25  "regulated medical
waste,"26 "biomedical waste,"27 "red bag waste,"28 and "infec-
tious waste"29 appear in state and federal laws and guide-
lines. There is currently no objective test to determine when
a solid waste is medical or infectious waste, and a policy de-
bate continues over how to classify infectious and other medi-
cal waste. 30 Presently, health care facilities can follow either
EPA or Centers for Disease Control (CDC) guidelines, or both
in designating medical waste.31 The two agencies have differ-
ing definitions of infectious waste; this contributes to the lack
of consistent data on the amount, composition, and types of
medical waste in our waste stream. Moreover, the ultimate
designation infectious waste receives impacts on the costs of
24. OTA BACKGROUND PAPER, supra note 2, at 7.
25. Id. at 4.
26. OTA REPORT, supra note 3, at 2.
27. OTA BACKGROUND PAPER, supra note 2, at 14.
28. Id. at 9.
29. Id. at 3.
30. Id. According to EPA, "developing a uniform definition of medical waste
that is easy for the regulated community (under the Medical Waste Tracking
Act) to understand and implement and for EPA to enforce has been problem-
atic." ENVIRONMENTAL PROTECTION AGENCY, MEDICAL WASTE MANAGEMENT IN
THE UNITED STATES, SECOND INTERIM REPORT TO CONGRESS 26 (1990) [hereinaf-
ter EPA SECOND INTERIM REPORT]. No universally accepted definition exists for
infectious waste; as a result, the various terminology used to define these
wastes is inconsistent. United States Environmental Protection Agency, Guide
for Infectious Waste Management 2-1 (1986) [hereinafter EPA Guide].
31. The OTA reports that a survey for the American Hospital Association
showed that 80 percent of the hospitals are following CDC guidelines and 52
percent comply with EPA guidelines. OTA BACKGROUND PAPER, supra note 2,
at 4 n.9.
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waste management and the methods of disposal chosen by
generators.3 2 It is likely that these costs are often passed on
to patients and insurers.
1. The EPA Definition
EPA defines infectious waste as waste "that contains
pathogens with sufficient virulence and quantity so that ex-
posure to the waste by a susceptible host could result in an
infectious disease," or, more simply, "waste capable of produc-
ing infectious disease."33 This definition requires considera-
tion of four factors necessary for the induction of disease:
presence of a pathogen of sufficient virulence; dose; portal of
entry; and resistance of the host.34 EPA lists six infectious
waste categories: (1) isolation wastes, (2) cultures and stocks
of infectious agents and associated biologicals, (3) human
blood and blood products, (4) pathological wastes, (5) contam-
inated sharps, and (6) contaminated animal carcasses, body
parts, and bedding.35 EPA includes additional materials
such as contaminated equipment, wastes from surgery and
autopsy, laboratory wastes and dialysis wastes as wastes
which should be evaluated to determine potential infectious-
ness.36 These materials have not been specifically designated
as infectious because of a lack of information on the relative
risk they pose. EPA therefore recommends that "a responsi-
ble authorized person or committee at the individual facility
evaluate these wastes to determine which should be managed
as infectious waste."37 Individual facilities thus have much
discretion in characterizing products in their waste stream as
infectious; there is consequently great disparity in the way
health care facilities treat their waste.
32. Id. at 4.
33. EPA Guide, supra note 30.
34. Id.
35. Id. at 2-2.
36. Id.
37. Id. The regulatory definition of "regulated medical waste" promulgated
pursuant to the MWTA at 40 C.F.R. § 259.10 (1989) originally contained ten
categories of regulated medical waste. It expired with the MWTA demonstra-
tion program. 40 C.F.R. 259.10 (1989).
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2. The Centers for Disease Control Definition
In 1987 the Centers for Disease Control (CDC) issued
recommendations called "universal precautions" to health
care facilities for classifying waste as infectious.38 CDC rec-
ommended that blood and body fluids from all patients be
considered potentially infected with HIV and/or other blood-
borne pathogens and that health care workers adhere rigor-
ously to infection control precautions. 39  The
recommendations were apparently interpreted by some hos-
pitals as classifying virtually all patient-contact waste as in-
fectious, which could amount to 70 to 90 percent of all
hospital waste.40 As a result of confusion and concern that
the recommendations were too broad, in 1988 CDC attempted
to clarify the 1987 guidelines and limited application of the
universal precautions to blood, body fluids containing visible
blood, and other specified fluids.41
Both CDC and EPA consider pathological waste, blood
and blood products, contaminated sharps and microbiological
wastes to be infectious.42 The agencies disagree over
designation of communicable disease/isolation wastes be-
cause EPA considers communicable disease wastes infectious
and CDC recommends that such wastes be treated according
to hospital policy. 43 Such disagreements can have significant
financial impacts on a generator attempting to determine
how much of its waste is indeed infectious. For example, "one
600-bed hospital found it saved $250,000 annually by chang-
ing its infectious waste designation from 13 categories to the
38. CENTERS FOR DISEASE CONTROL, UNIVERSAL PRECAUTIONS FOR PREVEN-
TION OF TRANSMISSION OF HIV AND HEPATITIS B VIRUS (1987), discussed infra at
section VII.
39. Id.
40. OTA BACKGROUND PAPER, supra note 2, at 4.
41. Id. at 5.
42. OTA BACKGROUND PAPER, supra note 2, at 5.
43. Id. at 6. According to the OTA, given the state of confusion at the gener-
ator level as to what is infectious waste requiring special handling, EPA, per-
haps jointly with CDC, needs to publish further guidance on these definitional
issues. Id.
19941 525
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four designated by the CDC."44 Given the EPA and CDC defi-
nitional differences, it is not surprising that accurate, consis-
tent data on the amount of medical waste generated in the
United States is difficult to find. This problem is com-
pounded by the fact that other regulatory agencies such as
the Occupational Safety and Health Administration and the
Department of Transportation also have their own unique
definitions of medical waste or infectious substance. 45
C. Characteristics of the Infectious Waste Stream
1. Amounts of Medical Waste
Data on the amounts of medical and infectious waste in
the United States vary. In its second report to Congress
under the Medical Waste Tracking Act, EPA stated that col-
lecting baseline information on medical waste generation and
waste management practices and costs has been "problem-
atic" because most facilities, particularly small quantity gen-
erators, generally did not maintain records, and because
waste management practices vary widely between facilities. 46
EPA estimates that each hospital has a per bed, per day gen-
eration rate of 13 pounds of medical waste.47 Other in-
dependent estimates of medical waste generation range from
44. Id. at 4. The OTA reports that most estimates are that 10 to 15 percent
of all hospital wastes are infectious. However, depending on the definitions
used, the total range of estimates is from 3 to 90 percent of a hospital's waste.
Id.
45. OSHA regulations related to medical waste are discussed, infra, note
273. Dept. of Transportation regulations on hazardous materials are at 49
C.F.R. §§ 171, 172, 173 (1992).
46. EPA SECOND INTERIM REPORT, supra note 30, at 28. As part of its third
and final report to Congress, EPA is preparing a Waste Characterization Study
which will analyze the generation of medical waste to determine the physical
and chemical characteristics of the medical waste stream. See EPA SECOND
INTERIM REPORT, supra note 30, at 9. However, results of this study will not be
available until the final report is released to Congress. Telephone Interview
with Ann Coggington, supra note 23.
47. OTA BACKGROUND PAPER, supra note 2, at 3. These figures apply only
to sources producing more than 50 pounds of medical waste per month. Smaller
generators, such as medical clinics or dentists' offices, are not included.
10http://digitalcommons.pace.edu/pelr/vol11/iss2/2
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16 to 23 pounds per bed, per day.4 8 Not all of this waste, how-
ever, is infectious.
To evaluate and define the infectiousness of medical
waste requires knowledge of the type of pathogens present,
the quantities of those pathogens, potential modes of disease
transmission and information on the susceptible host popula-
tion.49 One study, which distinguishes between infectious
and medical waste in ascertaining amounts of generation, re-
ports that United States hospitals generate a median of 15
pounds of medical waste per patient, per day, with infectious
waste making up 15 percent of the total.50 This data is based
on a 1985 estimate of 1,300,000 hospital beds in 7,000 hospi-
tals in the United States, with an average occupancy rate of
69.5 percent.51 Extrapolating from this information, the total
generation of infectious waste by hospitals in the United
States is 375,000 tons per year.52 Clearly, the amount of in-
fectious waste generated by medical facilities as a percentage
of their total waste stream varies widely depending on the
type of health care facility, the definition of infectious waste
used and the procedures used to designate and separate
waste types.53 Most hospitals designate about 15 percent of
their wastes as infectious.54
48. Id.
49. EPA FIRST INTERIM REPORT, supra note 4, at 1-4.
50. C.C. Lee et al., Medical Waste Management-The State of the Art,
ENVTL. Sci. & TECH., Mar. 1991 at 360-61 (citing P. LAYNE ET AL., REVIEW AND
EVALUATION OF EXISTING LrERATURE ON GENERATION, MANAGEMENT AND PO-
TENTiAL HEALTH EFFECTS OF MEDICAL WASTE, DRAFT REPORT OF RESEARCH TRI-
ANGLE INSTITUTE (Nov. 1988)).
51. Id.
52. Id. See also Council Report on Infectious Medical Waste, 262 JAMA
1669 (Sept. 22, 1989). If the EPA definition is used, about 15 percent of the 750
to 800 million pounds of total waste generated by United States hospitals each
year is potentially infectious. Assuming such is the case, the daily output of
infectious waste is estimated to be 1.5 pounds per bed. Id.
53. OTA REPORT, supra note 3, at 2.
54. Id. In order to reduce its medical waste, one hospital has undertaken a
recovery and recycling program called "REMEDY" (Recovered Medical Equip-
ment for the Developing World) whereby it donates to developing countries cer-
tain used medical equipment which might otherwise be disposed of as "waste."
See William H. Rosenblatt & David G. Silverman, Recovery, Resterilization, and
Donation of Unused Surgical Supplies, 268 JAMA 1441 (1992).
1994] 527
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2. Sources of Medical Waste
Hospitals, however, are not the sole source of infectious
medical waste. It has been estimated that hospitals account
for less than 2 percent of the total number of facilities with
the potential to generate infectious waste.55 In addition to
hospitals, other types of health care facilities contribute to
the medical waste stream; however, the amount of medical
wastes from such non-hospital sources is not known.56 A
Washington State Infectious Waste Project identified funeral
homes, nursing homes, veterinarians' offices, laboratories,
surgery centers, clinics, dentists' offices, and research facili-
ties as the main non-hospital producers of medical waste.57
One source states that in terms of the number of facilities
that potentially generate medical waste, the categories iden-
tified in the Washington study account for more than 98 per-
cent of the total, which is estimated at 340,500 facilities. 58
By comparison, another source reports that approximately
465,000 tons of infectious waste are generated in the United
States each year by 377,000 health care facilities including
non-hospital sources. 59
Even less is known about other sources of medical waste,
such as syringes generated in home health care and by illegal
55. See Lee et al., supra note 50. But, based on information gathered from
five participating states during the initial phase of the MWTA demonstration
program, the EPA reported that the vast majority of medical waste (about 90
percent) is produced by hospitals, which comprise about four percent of the gen-
erators reporting data. EPA SECOND INTERIM REPORT, supra note 30, at 32.
56. OTA BACKGROUND PAPER, supra note 2, at 3.
57. WASHINGTON STATE DEPARTMENT OF ECOLOGY, SOLID AND HAZARDOUS
WASTE PROGRAM, REPORT TO THE LEGISLATURE: WASHINGTON STATE INFECTIOUS
WASTE PROJECT (1989).
58. Lee et al., supra note 50, at 361. Other sources include approximately
180,000 physicians' offices, 98,400 dentists' offices, 38,000 veterinarians' offices,
15,500 medical clinics, 12,700 long-term health care facilities, 4,300 laborato-
ries and 900 free-standing blood banks. William A. Rutala & David J. Weber,
Infectious Waste-Mismatch Between Science and Policy, 325 NEW ENG. J.
MED., Aug. 22, 1991, Vol. 325, at 578 (citing EPA FIRST INTERIM REPORT, supra
note 4). The authors maintain that although these sources may have a signifi-
cant contribution to the medical waste stream the amount of that contribution
is uncertain as no reliable data exists. Id.
59. MEDICAL WASTE INCINERATION AND POLLUTION PREVENTION 43-44 (Alex
E.S. Green ed. 1992).
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drug users. It is estimated that there are 2,000,000 diabetics
and 1,200,000 intravenous drug abusers nationwide; between
the two groups, more than 1 billion insulin-type syringes are
used annually, the disposal of which is not regulated.60
These two waste streams are now receiving more attention.
In its Second Interim Report to Congress, EPA admits that
the extent to which these waste streams contribute to the
problem of beach wash-ups and other mismanagement inci-
dents is unclear; some of the medical debris discovered on
beaches, however, has been linked to disposal of insulin syr-
inges. 61 One recent survey indicates that diabetics dispose of
an estimated 1.4 billion needles every year; home health care
for people suffering from AIDS, cancer and other chronic dis-
eases also generates medical wastes.62 EPA has acknowl-
edged that the home health care community is the most
significant unregulated medical waste source that it has at-
tempted to reach.63
Another component of the medical waste stream is waste
produced by small quantity generators. The contribution of
this community is nearly impossible to assess since it is not
stringently regulated (unless the generator produces hazard-
ous waste regulated under RCRA), and the MWTA exempted
small quantity generators from reporting.64 More precise
data is needed on non-hospital sources of medical waste and
60. Rutala & Weber, supra note 58, at 579 (citing AGENCY FOR Toxic SuB-
STANCES AND DISEASE REGISTRY, THE PUBLIC HEALTH IMPLICATIONS OF MEDICAL
WASTE: A REPORT TO CONGRESS (1990) thereinafter ATSDR REPORT].
61. EPA SECOND INTERIM REPORT, supra note 30, at 17, 26-27. Over half of
the medical waste items collected by six states during the 1988 beach season
wash-ups were syringe related. A number of states concluded that home health
care and illegal intravenous drug use were the most likely sources of this waste.
Id. at 10 (citing ENVIRONMENTAL CRIMES UNIT, MARYLAND ATTORNEY GENERAL'S
OFFICE, MEDICAL WASTE INVESTIGATION REPORT (1988)).
62. Ingfei Chen et al., Medical Wastes Come Home, HEALTH, May/June
1993, at 21.
63. EPA FIRST INTERIM REPORT, supra note 4, at 11-1 to 11-29. Recognizing
the growing significance of this waste stream, EPA has developed a home
health care waste education program and published substantive guidance for
the disposal of home health care medical waste. Id.
64. Medical Waste Tracking Act of 1988, Publ. L.No. 100-582, 102 Stat.
2950 (codified as amended in sections of 69 U.S.C.).
1994] 529
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how they may contribute to combined sewer overflows or
other types of medical waste mismanagement.
3. Composition of the Medical Waste Stream
Waste generated at health care facilities is heterogene-
ous, varying in composition and in quantity. This is because
such facilities offer a variety of services and engage in differ-
ent activities. The types of wastes produced by a health care
facility can be characterized as infectious, noninfectious solid
waste and hazardous waste.65 Since there is no universal
definition of the term "infectious waste," there is no clear def-
inition of the category. State, local and federal regulating
bodies develop their own definitions. 66 Generally, infectious
waste includes materials considered to be potential health
hazards because of possible contamination with pathogenic
microorganisms. 67 The typical waste stream components of
infectious waste in order of magnitude are paper and cloth
items, plastics, glassware and fluids.68
Health care facilities also produce noninfectious solid
waste which includes many items found in municipal solid
waste. Most often accounting, engineering, record keeping
and other administrative functions generate these wastes. In
order of quantity, these noninfectious solid wastes include pa-
per and cardboard, plastics, food scraps, metal glass, inor-
ganic materials and other miscellaneous matter.69
Depending on the applicable regulation, most patient-care
generated waste may be considered noninfectious assuming
the absence of exposure to infectious agents. 70
65. Low level radioactive wastes are another common hospital waste prod-
uct; however, they are separately regulated and beyond the scope of this paper.
See generally Moira Hayes, Radioactive Marine Pollution: International Law
and State Liability, 15 SUFFOLK TRANSNAT'L L.J. 674 (1992) for a discussion of
radioactive medical waste and the history of radioactive waste regulation.
66. FRANK L. CROSS, INFECTIOUS WASTE MANAGEMENT 8 (1990).
67. GREEN, supra note 59, at 40.
68. Id. at 42. Factors affecting the amount of these elements present in the
waste stream include the extent of laboratory and research activities conducted,
number of surgeries, and use of disposables. CROSS, supra note 66, at 10.
69. GREEN, supra note 59, at 40.
70. CROSS, supra note 66, at 9-10.
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RCRA regulates hazardous waste generated by health
care facilities. This waste is frequently produced by chemo-
therapy units and in the use and disposal of solvents, and
may include waste pharmaceuticals, cytotoxic agents, mer-
cury and other heavy metals.7 ' RCRA regulations subject
hazardous waste generators to different standards according
to the quantity of waste produced per month. 72 Some propo-
nents of stringent infectious waste regulation argue that clas-
sifying infectious waste as hazardous is desirable in order to
prosecute illegal dumping as a felony, to institute a manifest
system for infectious wastes which would track off-site move-
ment of these wastes, and to ensure greater comprehensive
infectious waste management. 73
The medical waste stream has not changed significantly
in the past few years. 74 The most noticeable change is the
increase in plastic disposable items. 75 An increase in plastics
has disposal implications, especially if the waste is inciner-
ated, because hydrogen chloride production and furan and di-
oxin emissions change with the amount of polyvinyl chloride
incinerated. 76
When compared to the municipal waste stream, the com-
position of the medical waste stream appears very similar.
The main differences between the municipal and medical
waste stream compositions are in plastic and paper concen-
trations.77 Infectious waste contains approximately 41 per-
cent plastic and rubber while municipal solid waste contains
71. Id. at 3. Typical hazardous wastes produced by health care facilities
include antineoplastic drugs generated in chemotherapy units, solvents such as
xylene and toluene, and certain forms of formaldehyde. Id.
72. 42 U.S.C. § 6992b(b) (1988).
73. OTA BACKGROUND PAPER, supra note 2, at 7 (citing New York State's
statute N.Y. C.L.S. E.C.L. § 71-2713 which provides for penalties of up to 4
years in prison and fines of up to $50,000 for illegal disposal of medical wastes).
74. CRoss, supra note 66, at 1.
75. Id. According to GREEN, supra note 59, at 45, the use of plastics to re-
place glass and textiles has caused the amount of plastic in the waste stream to
increase from 10 percent in the late 1970s to more than 30 percent in the late
1980s.
76. GREEN, supra note 59, at 45. See discussion of incineration infra at sec-
tion IV.
77. GREEN, supra note 59, at 42.
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12.8 percent.78 Municipal solid waste contains 54.1 percent
paper and cardboard, while infectious waste contains 31
percent.79
Not everyone is convinced that infectious waste poses a
major health risk to the public. To support this position some
argue that certain common pathogens such as group D strep-
tococci are more prevalent in household waste than medical
waste, and they further maintain that soiled diapers are a far
greater hazard than the typical bag of infectious waste.80
The actual risk posed by infectious waste is still under de-
bate, and the uncertainty of this issue underlies EPA's deci-
sion not to regulate the waste as hazardous.
III. Medical Waste and the Public Health Debate
A. Introduction
The degree of risk posed by medical waste is unclear.
There are three main areas of concern: risks to the general
public health, risks of occupational exposure, and risks asso-
ciated with disposal and treatment technologies."' Potential
risks associated with medical waste were tentatively ac-
knowledged prior to 1988; however, it has been the incidents
of medical waste mismanagement that excited public and me-
dia attention and forced governmental action. 2 For instance,
in 1986 the New York City Fire Department discovered ap-
proximately 1,400 bags of medical waste at a warehouse, and
in 1987 in Indianapolis, 12 children were found playing with
78. Id.
79. Id.
80. COUNCIL REPORT ON INFECTIOUS MEDICAL WASTES, supra note 52, at
1669 and writings cited therein.
81. There may also be risks to the environment associated with medical
waste such as through beach wash-ups of infectious material or incineration of
hazardous medical waste; however, the focus of this paper is on public health
risks. The EPA concluded that "[miedical waste adversely affects the environ-
ment. Generally, this waste stream contributes to the overall environmental
problem of solid waste disposal in the United States. Specifically, beach wash-
ups and products of incomplete combustion are among the adverse environmen-
tal effects of inadequate medical waste management." ATSDR REPORT, supra
note 60, at E.11.
82. The legislative history of the MWTA supports this conclusion and is dis-
cussed in more detail infra at section IV.
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AIDS-infected vials of blood that came from an unlocked
dumpster outside several doctors' offices.8 3
The outcry such incidents created may have contributed
to the recent growth in state legislation regarding medical
waste. Nevertheless, the federal government is not convinced
that risks associated with medical waste mismanagement
warrant a scheme of federal regulation. Congress first ad-
dressed the potential hazards of medical waste indirectly in
1976, defining "hazardous waste" in the Resource Conserva-
tion and Recovery Act (RCRA) to include wastes with infec-
tious characteristics.8 4 Despite this, medical waste was not
actually regulated until 1988 when Congress passed the Med-
ical Waste Tracking Act (MWTA). Despite passage of the
MWTA, very little epidemiological study of public health risk
associated with medical waste exists.8 5 To date, the Agency
for Toxic Substances and Disease Registry (ATSDR) reports
the most extensive federal research on this issue.86
B. ATSDR Findings and EPA Health Hazard Assessment
ATSDR issued its report in September 1990 describing
the "potential for infection or injury from the segregation,
handling, storage, treatment or disposal of medical waste"
from all sources of generation. 7 The agency found that for
infection to happen a chain of events must occur: a person
must come into contact with medical waste; an injury must
follow, thereby creating a portal of entry (or a portal of entry
must already exist); a sufficient number of viable infectious
agents must enter a susceptible host via the portal; infection
83. Lee et al., supra note 50, at 360 (citing OTA BACKGROUND PAPER, supra
note 2).
84. 42 U.S.C. § 6903(5) (1988).
85. Telephone Interview with Ann Coggington, supra note 23.
86. The MWTA, supra note 64, section 11009, required ATSDR to report on
the public health implications of medical waste. 42 U.S.C. § 6992(g)(a)(2).
87. See ATSDR REPORT, supra note 60. For a discussion of the methodology
ATSDR used, see Sven E. Rodenbeck and Maureen Y. Lichtveld, Report to Con-
gress: The Public Health Implication of Medical Waste, J. ENvTL. HEALTH, Jul.
1990, at 30.
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can then occur, but does not always result in disease.88
ATSDR found that "an infectious organism's ability to sur-
vive outside a host varies widely and, consequently, its capa-
bility to transmit disease varies greatly, depending on its
type and form and environmental factors such as tempera-
ture and moisture."8 9 Viruses such as hepatitis B and the
human immunodeficiency virus (HIV), "must be inside a liv-
ing cell to multiply and once removed from a living cell, their
numbers may remain constant or decline, but may never
increase."90
ATSDR arrived at 16 conclusions based on the data it de-
veloped. Most significantly, the agency concluded that the
"general public's health is not likely to be adversely affected
by medical waste generated in the traditional health care set-
ting."91 Outside the health care setting, the potential for hep-
atitis B virus or HIV infection in the general public following
medical waste-related injuries is unlikely to be a health con-
cern. 92 However, the number of persons infected with HIV is
expected to increase; likewise, the number of health care
workers infected with AIDS is anticipated to rise as a result
of contact with waste sharps, thereby increasing the potential
88. ATSDR REPORT, supra note 60, at E.5. Of all these requirements, an
appropriate portal of entry is the most important determinant in the infectious
disease transmission process. Since medical sharps are capable of creating
such a portal, injuries from sharps have the greatest potential to cause infection
and disease. ATSDR concludes that because most medically related injuries
from sharps occur during patient care, the health care setting presents the
greatest potential for infectious disease transmission. Id.
89. Id. at E.2.
90. Id. at E.3.
91. Id. at E.9.
92. Id. Maureen Y. Lichtveld, an ATSDR toxicologist, reports that AIDS
infection as a result of contact with medical waste is unlikely because the virus
is too fragile. However, risks to sanitation workers and home health care prov-
iders as a result of hepatitis B and bacterial infection contamination are rising
because of the enormous expansion of the home health care industry and the
lack of regulation of home health care waste disposal. Chen et al., supra note
62, at 22. Used syringes and intravenous tubing are often tossed into the trash
or flushed down the toilet. Of the needle-stick injuries reported by sanitation
workers, 14 percent occur in residential neighborhoods and this percentage is
increasing. Id. at 21.
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for medical waste-related HIV transmission in the health
care setting. 93
ATSDR emphasizes that limited data is available on
communicable disease potentially attributable to medical
waste. 94 Theoretical estimates vary extensively due to differ-
ent study designs, reporting practices and sources of records
or case information. 95 In conclusion, the agency makes
eleven recommendations. Among them, ATSDR suggests
that research is needed in three specific areas: to evaluate
the probability of infection following contact with body fluids
previously exposed to the environment; to evaluate the likeli-
hood of medical waste-related diseases caused by infectious
agents other than HIV and hepatitis B virus; and to deter-
mine the chemical constituents of incinerator stack emission
and their mutagenicity. 96
In addition to ATSDR's report, section 11008(a)(2) of the
MWTA required EPA to evaluate the threat posed by medical
waste.97 In its first interim report to Congress, EPA proposed
a methodology for assessing the potential health hazards and
is currently analyzing approximately 70 classes of pathogenic
bacteria, viruses, fungi and protozoa that may be present in
health care facilities, focusing on their potential role in infec-
tion.98 Working in consultation with ATSDR, EPA is prepar-
ing a Health Hazard Assessment Report which it will release
with its third and final report to Congress under the
93. ATSDR REPORT, supra note 60, at E.10.
94. Id. at E.11.
95. Id. at E.11. ATSDR's report is based on data provided by the New York
City Department of Sanitation, Browning-Ferris Industries Corporation, 17
state health departments and the Department of Defense. According to the re-
port, the data were self-reported.
96. Id. at E.14-15.
97. MWTA, supra note 64.
98. EPA SECOND INTERUM REPORT, supra note 30, at 35-37. This analysis
focuses on those wastes warranting concern for public exposure. EPA is als6
collecting information on infective dose and survivability of pathogens, and per-
forming epidemiological data searches (other than those performed by ATSDR)
for disease transmission from exposure to medical waste either in the work-
place or community. Id.
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MWTA.9 9 The agency acknowledges that "[miany experts
and health care professionals have expressed opinions that
any health hazards posed by medical waste are occupational
and that actual threats to the general public are unlikely,
even when such wastes are mismanaged or improperly dis-
posed."100 EPA concludes that determining the potential
health hazards of improperly managed medical waste is "one
of the most complex and critical issues requiring
resolution."' 0
C. Three Types of Risks
1. Risk to the General Public
At least one prominent researcher working in the infec-
tious waste field claims that no evidence exists that medical
waste has lead to disease "outside of a healthcare facility,"
and that the fear of AIDS, "fueled by misleading media cover-
age," has prompted regulation of medical waste.102 Some ar-
gue the "crisis" in medical waste which spurred regulatory
growth in the 1980s and early 1990s is "primarily a function
of hysteria brought on by repugnance to the nature of the
waste and phobia of infection."10 3 The OTA has stressed that
99. Telephone Interview with Ann Coggington, supra note 23. Ms. Cog-
gington did not indicate when the report would be released. After preliminary
study, the agency has reported that information collected on survivability of
bacteria and viruses show rapid die-off of pathogens exposed to various environ-
mental conditions. However, according to Tom Goldberg, the data now avail-
able is old and the government is not currently funding any further research in
this area. Telephone Interview with Tom Goldberg, supra note 6.
100. EPA FIRST INTERIM REPORT, supra note 4, at 2-1.
101. Id. at 2-2. According to EPA "[tihe key question is which components of
the medical waste stream pose true health hazards and, therefore, require some
type of regulatory control." Id. at 2-2 to 2-3.
102. Rutala & Weber, supra note 58, and William A. Rutala, Medical Waste,
INFECT. CONTROL & Hosp. EPIDEMIOLOGY, Jan. 1992, at 38. Rutala contends
that regulation of medical waste has been based on a lack of understanding of
the modes of transmission of infectious agents, the fear of AIDS, and the dis-
trust of health care facilities. He argues that many of the rules developed by
states for regulation of medical waste have no scientific basis; therefore, these
rules vary widely in content, often conflict, and will ultimately increase health
care costs. Id. at 39.
103. David R. Mercer, A Prospectus on the Legislative Response to Medical
Waste, 55 Mo. L. REv. 510, 515 (1991) and sources cited therein at footnote 40.
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an important fundamental policy issue which the federal gov-
ernment should address is the extent of medical waste regu-
lation on the basis of potential threat to public health and
aesthetic characteristics. 10 4 The existing data indicates that
general debris comprised the majority of waste found on
beaches after medical waste wash-ups; medical waste could
not be traced to illegal dumping or a specific source, but prob-
ably resulted from sewage overflow. 10 5 EPA attributed the
medical waste problem to illegal disposal, combined sewer
overflow, storm water runoff, beach litter, legitimate home
use of syringes, illegal drug users and the generally inade-
quate handling of solid wastes at landfills and coastal trans-
fer facilities. 0 6 Consequently, many believe it unlikely that
the general public will contact medical waste. However, ac-
cording to the Centers for Disease Control, "'contaminated
needles or sharps, human blood and blood products, patholog-
ical parts and laboratory wastes possess real potential to
transmit disease.'"107 Nevertheless, contaminated sharps
are the only medical waste ever associated with infectious
disease transmission. 10 8 According to one theoretical esti-
mate, the probability of a person developing HIV infection
from a needle on the beach is between one in 15 billion and
one in 390 trillion. 10 9
Few studies quantify the infectious microbial loads of dif-
ferent hospital wastes. Those existing indicate hospital
104. OTA REPORT, supra note 3, at 5.
105. Rutala, supra note 102 at 38 (citing INVESTIGATION: SOURCES OF BEACH
WASH-UPS IN 1988, NEW YORK STATE DEPARTMENT OF ENVIRONMENTAL CONSER-
VATION REPORT, Albany, New York (1988)). About 65 percent of the waste was
syringe-related and was generated from home health care and illegal intrave-
nous drug use. "The amount of medical waste in the form of plastic syringes,
collected on the beaches of 23 coastal states, constituted less than 0.1 percent of
the total debris found." Id. at 41 and sources cited therein.
106. Health Hazards Posed in the Generation, Handling, and Disposal of In-
fectious Wastes: Hearing Before the Subcommittee on Regulation and Business
Opportunities of the House Committee on Small Business, 100th Cong., 2d Sess.,
78 (1988) (statement of Jeffrey D. Denit, Deputy Director, Office of Solid Waste,
EPA).
107. Mercer, supra note 103, at 513 (citing 134 CONG. REC. S10,738 (daily ed.
Aug. 3, 1988) (statement of Sen. Lautenberg)).
108. Rutala, supra note 102, at 41 (citing ATSDR REPORT).
109. Id.
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waste to be no more contaminated with microorganisms than
household waste.110 Some researchers have concluded that
household waste contains on average 100 times more micro-
organisms with pathogenic potential for humans than hospi-
tal waste."' In fact, contaminated sharps are the only
medical waste that has been associated with infectious dis-
ease transmission.1 12 In sum, sparse evidence supports a
medical waste-disease connection. Based on the data avail-
able, it appears the optimum, albeit difficult, way to reduce
public exposure through wash-ups is to regulate home health
care and intravenous drug use, to ensure proper disposal of
municipal waste, and to prevent mechanical failures in sew-
age systems of coastal cities.
2. Occupational Risks
In the health care setting, the persons most often injured
are nurse's aides, registered nurses, and housekeeping, main-
tenance and food-preparation workers. 113 Of all workers con-
tacting medical waste, sanitary service workers report the
highest rates of on-the-job injuries. 114 Many medical waste-
related injuries reported come from contact with sharps; how-
ever, only one case of infection possibly associated with the
handling of medical waste sharps has been reported. 115 Ac-
110. Wayne L. Turnberg, Infectious Waste Disposal, An Examination of Cur-
rent Practices and Risks Posed, J. ENvrL. HEALTH, May 1991, 21, 23.
111. Rutala and Weber, supra note 58, at 581. One study conducted by the
Seattle/King County Department of Public Health concluded that because orga-
nisms capable of causing infection are a part of normal household waste, un-
treated residential waste may be as infectious as most untreated medical waste.
See Turnberg, supra note 110. See also WASH. STATE DEPT. OF ECOLOGY, RE-
PORT TO THE LEGISLATURE, WASH. STATE INFECTIOUS WASTE PROJECT (1989).
112. Rutala, supra note 102, at 41.
113. ATSDR REPORT, supra note 60, at E.3. "The annual injury rates for
these occupations vary from 10 to 20 per 1,000 workers. Most work-related in-
juries among health care workers are sprains and strains due to overexertion."
Id.
114. Id. Sanitary service workers' "overall injury rate of 180 per 1,000 work-
ers per year is more than double that of the entire United States work force
combined. Injuries are most frequently reported as strains and sprains caused
by overexertion." Id.
115. Id. at E.6. According to ATSDR and Rutala, supra note 102, there is no
documented evidence on infections resulting from contact with medical waste
22http://digitalcommons.pace.edu/pelr/vol11/iss2/2
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cording to studies, waste industry workers who were exposed
to medical and municipal waste did not exhibit an increased
risk of bloodborne infections. 116 The Centers for Disease Con-
trol, however, once reported that each year 200 to 300 deaths
occur among health care workers, often waste handlers, due
to hepatitis B. 117
The exact nature and degree of the risk to medical work-
ers thereby remains an open question, with little current em-
pirical data to resolve the debate. In its report, the ATSDR
recommended that work practices of the occupational sub-
groups frequently contacting medical waste should be evalu-
ated to determine appropriate protective measures and that
occupational health and surveillance data for higher risk
groups should be collected."" Conflicts in the existing data,
other than sharps. ATSDR REPORT, supra note 60, at E.8. None of the HIV
infections attributed to dermal contact or mucous membrane contamination
were associated with medical waste. ATSDR estimates that there is a theoreti-
cal possibility that a maximum of 1 to 4 cases of AIDS per year could occur as a
result of contact with medical waste sharps. Id. at E.10. Contact with non-
sharp medical waste may contribute to the total number of hepatitis B virus
and HIV cases, but this contribution is likely to be insignificant, as a portal of
entry would already have to exist for disease transmission to occur. Id. at E.8.
By comparison, infection resulting from patient contact in the occupational set-
ting is much higher. See e.g. American Dental Association v. Martin, 984 F.2d
823 (7th Cir. 1993), wherein the court notes that as of 1991, "there had been 24
confirmed cases of United States health care workers infected with the AIDS
virus by patients since AIDS was first diagnosed in 1981." About 200 health
worker deaths per year are attributable to hepatitis B infection communicated
by patients. This figure is approximately 100 times greater than the number of
health workers infected each year by patient-communicated HIV. Id. at 824.
116. See Rutala, supra note 102, at 44 and studies cited therein.
117. 134 CONG. REC. H9541 (daily ed. Oct. 4, 1988) (statement of Rep.
Wyden). The study further concludes that many of these deaths can be traced
to exposure to infectious materials. Moreover, the CDC reports that each year
at least 18,000 people contract hepatitis B through accidental contact with med-
ical wastes. 134 CONG. REC. H9536 (daily ed. Oct. 4, 1988) (statement of Rep.
Luken). The hepatitis B virus can spread through breaks in the skin or through
contact with mucous membranes. The risk of acquiring hepatitis B infection
due to a needlestick injury from a needle contaminated by a hepatitis carrier
ranges between 6 to 30 percent within health care settings. Michael R. Shu-
maker, Infectious Waste: A Guide to State Regulation and a Cry for Federal
Intervention, 66 NOTRE DAME L. REv. 555, 561 n.21 (1990).
118. ATSDR REPORT, supra note 60, at E.13.
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and the general lack of data surrounding the occupational
risk posed by medical waste, support this recommendation.
3. Risks Associated with Treatment and Disposal
Medical waste can be effectively treated by chemical,
physical or biological means such as incineration, chemical
decontamination, autoclaving, irradiation and sanitary sew-
age treatment. Incineration is the most common method of
treating medical waste, and is the practice of approximately
64 to 93 percent of reporting hospitals. About one-third of
United States hospitals steam sterilize their microbial waste,
about one-fourth pour liquid blood down a drain connected to
a sanitary sewer, and the remaining unregulated medical
waste is often dumped in a sanitary landfill."19 Due to in-
creased disposable plastic use, older and less efficient inciner-
ators have the potential to produce incompletely burned
chlorinated by-products. Exposure to these substances may
cause adverse health effects. 120 Insufficient data are avail-
able to determine the adverse public health effects associated
with medical waste incineration, and the health implications
of medical waste incineration as compared to municipal solid
waste incineration are vigorously debated. 121
119. Rutala, supra note 102, at 44 (citing his own unpublished research
data). See also Rutala & F.A. Sarubbi, Management of Infectious Waste from
Hospitals, 4 INFECT. CONTROL 198-204 (1983).
120. Possible reasons for higher emission levels of dioxins and furans and
HCl in medical waste incinerators may be: (1) frequent startups and shut-
downs; (2) less stringent emission controls; (3) poorer combustion controls (e.g.,
waste mixing and oxygen controls); and (4) differences in the waste feed compo-
sition as compared with municipal solid waste. OTA BACKGROUND PAPER,
supra note 2, at 18. Studies have also shown that dioxins and furans can be
formed after leaving the furnace by the catalysts at low temperature of precur-
sors like benzene, and by chlorine atoms on fly ash particles. Id.
121. ATSDR REPORT, supra note 60, at E.13. See also OTA BACKGROUND PA-
PER, supra note 2, at 22, which states that the few risk assessments which have
been performed on individual hospital incinerators have predicted health risks,
specifically cancer, that are comparable to those predicted for municipal incin-
erators. But "no national estimates have been developed for aggregate cancer
risks from all hospital incinerators that can be compared with EPA's national
estimates for municipal incinerators. Additionally, no national estimates of
non-cancer effects associated with hospital incinerator emissions have been un-
dertaken." Id.
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The ATSDR finds that untreated medical waste can be
acceptably disposed in sanitary landfills because research in-
dicates that medical waste does not contain any greater
quantity of microbial agents than residential waste. Further-
more, viruses found in solid waste are generally adsorbed to
organic matter and become deactivated. 122 The potential
hazard of pathogens in landfills is a function of three condi-
tions: (1) the concentration and nature of the pathogen, (2)
the pathogen's ability to survive and retain its infectious
properties, and (3) the pathogen's ability to migrate through
the landfill into the surrounding environment and be a poten-
tial human hazard. 123 Research shows that the chemical and
physical characteristics of the landfill environment produce
an inactivating effect upon viruses and bacteria; however, it
acknowledges that it is possible for pathogens to survive. 124
On balance, it appears the risk of groundwater contamination
by pathogens in a properly lined and operated landfill is
low. 12
5
Discarding of medical waste via the sanitary sewer sys-
tem is arguably safe, assuming that conventional treatment
processes such as primary sedimentation, secondary biologi-
cal treatment and effluent disinfection reduce the microbial
content of raw sewage by 90 to 99 percent. But these percent-
ages depend on the type of microorganisms and the effective-
ness of specific treatment processes. 126 Proponents of sewer
system disposal of medical waste argue that the microbial
load added to the sewage flow via body fluid, such as blood, is
normally negligible compared with already existing major
sources of pathogenic microbes in raw sewage, which include
122. ATSDR REPORT, supra note 60, at E.11.
123. Turnberg, supra note 110, at 21, 23.
124. Id. at 24. See Rutala, supra note 102.
125. Turnberg, supra note 110, at 24. "Proper engineering and operation"
include use of the necessary liners and leachate collection systems to prevent
leaching of landfill contaminants to surface and groundwaters. Id. There have
been few scientifically designed experiments to measure for pathogens in
leachate or waters downstream from a landfill. OTA REPORT, supra note 3, at
15.
126. Rutala, supra note 102, at 45 (citing G. Bitton, INTRODUCTION TO ENVI-
RONMENTAL VIROLOGY 121-52 (1980). See also OTA REPORT, supra note 3, ch. 3.
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the bacteria and viruses in human feces. 127 The obvious
counter argument to this position is the possibility of sewer
overflow, or bypass or upset of the treatment works, which
could result in wash-ups exposing the public to infectious
wastes. Like incineration, the safety of the disposal of infec-
tious waste into the sanitary sewer system continues to be
aggressively debated.
Another primary alternative to incineration of medical
waste is autoclaving, which is considered an appropriate
methodology for treating 90 percent of medical waste, such as
microbiological laboratory cultures. 128 The demand for
autoclaving seems to be increasing because it is generally
cheaper than incineration and does not produce potentially
toxic emissions. 29 Other potential treatment technologies
such as irradiation, microwaving, electrohydraulic disinfec-
tion and plasma torch technology are also commercially avail-
able. The health risks associated with most non-incineration
technologies, however, have not been thoroughly investi-
gated.13 0 With the recent growth in alternative technologies
for treating and disposing of medical waste, needed research
on potential ancillary health risks of alternative technologies
will hopefully become available in the near future.
127. Rutala, supra note 102, at 45. Rutala maintains that, based on epide-
miological and microbiological data, only two types of medical waste require
special handling and treatment: sharps and microbiological waste.
128. OTA REPORT, supra note 3, at 27. Autoclaving or steam sterilization is
a process used to sterilize medical wastes prior to disposal in a landfill. It in-
volves the use of saturated steam within a pressure vessel at temperatures high
enough to kill infectious agents in the waste. Id. at 27-28. See infra section V
for a further discussion of incineration.
129. OTA REPORT, supra note 3, at 31, 39.
130. Id. at 38-39. OTA states that further examination of potential health
risks is warranted with alternative technologies, particularly for microwaving
and irradiation. While many of these alternatives can be viewed as supple-
ments to incineration, pathological wastes are one type of infectious waste for
which incineration remains the preferred treatment alternative because de-
struction is complete. Id. at 39.
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IV. The Beginning of Federal Regulation of Medical
Waste
A. Background
During the summers of 1987 and 1988 several northeast-
ern beaches were closed due to wash-ups of medical waste,
including used syringes, blood vials, rubber gloves, hypoder-
mic needles, and blood bags. In New Jersey, for example,
state health officials closed 50 miles of public beaches. 131
Public concern pressured governmental action and with unu-
sual speed, Congress passed the Medical Waste Tracking Act
(MWTA) in November 1988.132 The scope of the Act was lim-
ited to adding Subtitle J to RCRA and creating a two-year
demonstration program that ultimately only applied to four
states and Puerto Rico.133 There may be several reasons why
Congress chose to so limit the MWTA. Perhaps it concluded
that there was insufficient support for the legislation to over-
ride resistance from the hospital and medical community or,
perhaps it felt that the medical waste problem was essen-
tially an East Coast malady. 34 It is more probable that Con-
gress concluded a program of limited time, scope and federal
oversight would provide an opportunity to view a small-scale
program in operation before national commitment. 135
The statute and its implementing regulations expired on
June 22, 1991.136 Nevertheless, the MWTA remains signifi-
131. 134 CONG. REC. S20,111 (daily ed. Aug. 3, 1988) (statement of Sen.
Lautenberg). See also Mercer, supra note 103, at 509. New York and New
Jersey lost at least a billion dollars of tourism revenues due to these closings.
Id. at 516.
132. Medical Waste Tracking Act of 1988, Pub. L. No. 100-582, 102 Stat.
2950 (codified as amended in sections of 69 U.S.C.). When President Reagan
signed the MWTA, his action "marked the culmination of four months of fren-
zied legislative activity as Congress responded to strong public pressure that
arose after medical wastes washed ashore in the northeast." Mercer, supra
note 103, at 519 (citing NELSON A. ROCKEFELLER INST. OF GOV'T, REPORT OF THE
MEDICAL WASTE POLICY CoMMITTEE 2, at 25 (1989)).
133. Medial Waste Tracking Act of 1988, Pub. L. No. 100-582, 102 Stat. 2950
(codified as amended in sections of 69 U.S.C.).
134. See PERSPECTIVES ON MEDICAL WASTE, supra note 17, Supp: 3-7(1989).
135. Id.
136. Medical Waste Tracking Act of 1988, Pub. L. No. 100-582, 102 Stat.
2950 (codified as amended in sections of 69 U.S.C.).
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cant because it is the prototype for many existing state medi-
cal waste regulatory programs. 137 The four main features of
the Act which are reflected in a number of state statutes to-
day are: (1) a definition of medical waste; (2) a tracking sys-
tem similar to that for hazardous wastes; (3) information
gathering power and requirements; and (4) enforcement
capability.138
B. A Uniform Definition of Medical Waste
EPA created a new definition of medical waste under the
MWTA called "regulated medical waste."139 Unlike other
types of hazardous wastes addressed by RCRA, there is no
objective test for medical waste, therefore a consistent defini-
tion provided by the MWTA was critical to determining the
ways such waste would be regulated. The definition was
hotly disputed, particularly between the American Hospital
Association, the Natural Resources Defense Council and cer-
tain private parties.140 First, the MWTA defined medical
waste within RCRA as "any solid waste which is generated in
the diagnosis, treatment, or immunization of human beings
or animals, in research pertaining thereto, or in the produc-
tion or testing of biologicals."141 Then, the MWTA provided a
list of medical waste to be included under the program. 142
With the expiration of the MWTA, federally "regulated medi-
137. Cheryl L. Coon & Howard L. Gilberg, The New Regulatory Horizon:
Regulation of Medical Waste, 45 Sw. L.J. 1099, 1100 (1991-92).
138. Medical Waste Tracking Act of 1988, Pub. L. No. 100-582, 102 Stat.
2950 (codified as amended in sections of 69 U.S.C.).
139. 40 C.F.R. § 259.30(a) (1989).
140. For a discussion of these groups' individual viewpoints, see Onel, supra
note 10.
141. 42 U.S.C. § 6903(40) (1988 & Supp. III 1991).
142. 42 U.S.C. § 6992a(a)(1)-(11) (1988) is a listing of waste categories. In
order to exclude a waste from the list, EPA had to determine the specific item
did not "pose a substantial present or potential hazard to human health or the
environment when improperly treated, stored, transported, disposed of, or
otherwise managed." Id. § 6992(b). Ultimately, EPA eliminated some of the
categories and added a few specific items. The result was a list of seven catego-
ries of medical waste subject to the tracking provisions. According to one
source, "the MWTA provided Congress with a chance to do something, EPA
with the discretion to do relatively little, and the states with the authority... to
do as much or as little as they cared to do." Robert T. Nakamura et al., A Blip
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cal waste" no longer exists and there are a plethora of state
definitions. 143 Those who argue for a federal definition of
medical waste point out that state regulation of medical
waste is inconsistent, and since much of our medical waste is
transported across state lines, varying definitions create the
potential for disparate treatment of generators, transporters
and disposers.14 4
C. The Tracking System
EPA has stated that "the core of the MWTA consists of
the requirement that medical waste shipped off-site be
tracked to its destination." 45 The tracking system is based
upon the hazardous waste manifest system underpinning
RCRA Subtitle C.146 By making the tracking system the cen-
terpiece of the MWTA, Congress chose to focus on tracking of
existing medical waste rather than to change existing prac-
tices regarding disposal or treatment of medical waste.
Under the tracking system, once medical waste is generated,
the generator prepares a tracking form to accompany the
waste transported offsite from the facility. 47 The form ac-
companies the waste to the point of treatment and destruc-
tion or disposal and a copy of it is returned to the generator.
The regulations also address handling of the waste before
transport from the generator to the treatment and disposal
on the Radar Screen: Formulation and Implementation of the Medical Waste
Tracking Act, J. HFALTH, POL., POL'Y & LAw 299, 321 (Summer 1992).
143. For example, Florida uses "infectious, biohazardous waste," Georgia
and Connecticut use "biomedical wastes," and Iowa uses "medically hazardous
waste." See Shumaker, supra note 117, at 564, for a survey of state laws con-
cerning medical waste.
144. Id. at 598. See also B.J. Wynne III & Terri Hamby, Interstate Waste: A
Key Issue in Resolving the National Hazardous Waste Capacity Crisis, 32 S.
TEx. L. Rav. 601 (1991).
145. EPA SECOND INTERIM REPORT, supra note 30, at 6.
146. 42 U.S.C. 6901(c) (1988).
147. 42 U.S.C. § 6992b(a)(1) (1988). The MWTA tracking forms were similar
to manifests used to track Subtitle C wastes. If the generator did not receive
the appropriate portion of the tracking form sent with its waste back from the
disposal facility, it had to notify EPA as required by "Standards for the Track-
ing and Management of Medical Waste," 40 C.F.R. § 259.55(b) (1989). For a
discussion of divergent opinions on the tracking system, see Onel, supra note
10, at 240-44.
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facility.148 The pretransport requirements for medical waste
address labeling and marking of containers, segregating,
packaging and storing waste, and decontamination of reus-
able containers. Generators who ship more than 50 pounds of
regulated medical waste offsite per month are subject to pre-
transport, tracking form, recordkeeping and reporting re-
quirements, and they must ship waste with transporters who
have notified EPA of their intent to transport medical
waste. 149 Transporter vehicle standards are designed to con-
tain the waste and maintain packaging integrity during
transport. It was EPA's intention to construct a "closed cir-
cle" that facilitates proper management, encourages proper
disposal and reveals potential waste mismanagement. 150
Cost is a major factor weighing against treating medical
waste as hazardous waste. EPA concluded that the tracking
requirement imposed an average annual cost compliance of
$12,000,000, or $24,000,000 for the two years the program
would be run.' 5 ' While the MWTA's tracking system may
have been an effective means of providing baseline data on
medical waste, its cost is a potent disincentive which must be
weighed against the benefits of tracking.
D. Information Gathering
The MWTA provides that "any person who generates,
stores, treats, transports, disposes of, or otherwise handles or
has handled medical waste" must permit EPA to inspect doc-
uments and records relating to that waste, and to conduct
monitoring or testing, to enter sites, and to obtain samples. 152
Information gathering gives EPA a means to collect data for
reporting to Congress and supports the enforcement provi-
148. 40 C.F.R. § 259 (1989).
149. 40 C.F.R. § 259.50 (1989). See also PETER A. REINHARDT & JUDITH
GORDON, INFECTIOUS AND MEDICAL WASTE MANAGEMENT, 1990, App. A, for a
guide to MWTA medical waste tracking regulations.
150. 40 C.F.R. § 259.50 (1989).
151. EPA FIRST INTERIM REPORT, supra note 4, at 3-9. By comparison, EPA
estimated that New York, New Jersey and Connecticut alone would lose
$30,000,000 because of adverse effects attributable to mismanaged medical
waste. Id. at 3-16.
152. 42 U.S.C. § 6992c(a) (1988).
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sions of the Act. According to EPA, "[o]ne of the primary rea-
sons for developing a demonstration medical waste program
was to facilitate the collection and analysis of information
and data necessary for an informed discussion of the
problems associated with medical waste."153 There are five
"focal points" of EPA's data gathering and research efforts:
"[1] the characteristics of the regulated community; [2] the
physical, chemical and pathological characteristics of medical
waste; [3] the treatment, destruction and disposal methods;
[4] costs associated with the mismanagement of medical
waste and with the requirements of the Act; and [5] enforce-
ment and compliance with MWTA requirements." 154 From
this data, EPA is required by the MWTA to report to Con-
gress on specific issues.155 According to one commentator, "it
is in the information gathering sections of the Act that it be-
comes most evident that the Medical Waste Tracking Act is
not transitory relief to a fleeting crisis, but rather a prototype
for permanent federal legislation controlling all aspects of
medical waste."156 Yet in 1992, when EPA's final report was
two years overdue, one observer questioned the priority of
medical waste on the agency's agenda:
While a crisis can tilt the political balance in favor of regu-
lation, it cannot as readily produce the consensus required
to sustain regulation at the levels promised in the legisla-
tion. The window of opportunity opened by a convergence
of the various policy streams may remain open long
enough for authorizing statutes to be enacted. But... pas-
sage of legislation does not guarantee effective implemen-
tation .... 157
Although the MWTA program has lapsed and may never be
revived, its most palpable effect is still seen in some state pro-
153. EPA SECOND INTERIM REPORT, supra note 30, at 8.
154. Id.
155. EPA is required to prepare a final report to Congress at the end of the
MWTA demonstration program. 42 U.S.C. § 6992g-6992h (1988).
156. Mercer, supra note 103, at 546.
157. Nakamura, supra note 142, at 322.
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grams adopting the statute's tracking and controversial en-
forcement provisions.
E. Enforcement
During the MWTA demonstration program, some hospi-
tals were accused of overdesignating waste as "regulated
medical waste" as protection against the severe penalties for
violations. 158 Indeed, the MWTA contained strong enforce-
ment authorities similar to that of RCRA Subtitle C. In addi-
tion to the inspection and information gathering authorities
discussed, the agency could conduct monitoring or testing,
take samples, and have access to all facility medical waste
records. 159 The agency could issue compliance orders and as-
sess civil penalties of up to $25,000 per day for each viola-
tion.' 60 In the event records, reports, documents or material
information are knowingly falsified, or provisions of the
MWTA are knowingly violated, the MWTA incorporated
criminal sanctions subjecting the convicted violator to a fine
of not more than $50,000 per day of violation, or imprison-
ment of up to 5 years.16 1 If any person knowingly creates a
situation that places another person in imminent danger of
death or serious bodily injury, a criminal fine of up to
$250,000 or imprisonment of up to 15 years may be imposed;
a defendant organization may receive a criminal penalty of
up to $1,000,000.162 Those who disagreed with the severe
penalty structure argued that fines should be assessed rela-
tive to the seriousness of the violation. Proponents of the sys-
tem maintained that higher penalties would provide a
stronger deterrent value. 63
158. Rutala, supra note 102, at 46.
159. 42 U.S.C. § 6992c (1988).
160. 42 U.S.C. § 6992d(a)(4) (1988); see DONALD W. STEVEN & ELIZA A.
DOLIN, ENVIRONMENTAL LAW AND PRACTICE, 3-186 (1992).
161. 42 U.S.C. § 6992d(b) (1988).
162. Id. The orders for penalties were final unless a public hearing was re-
quested within 30 days. 42 U.S.C. § 6992d(a)(3) (1988).
163. 134 CONG. REC. H9538 (daily ed. Oct. 4, 1988) (statement of Rep. Whit-
taker) and 134 CONG. REC. H10,106 (daily ed. Oct. 12, 1988) (statement of Rep.
Schuette). For a discussion of the merits of stringent federal medical waste
legislation and enforcement, see Laurence D. Granite, The Medical Waste
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During the first year of the demonstration program, EPA
aggressively pursued eleven serious violations through ad-
ministrative actions, and issued 257 warning letters and for
less serious infractions, notices of violation.' 64 As of June 1,
1990, EPA reported it had conducted approximately 510 in-
spections and had assessed approximately $690,000 in penal-
ties.165 The final tally of enforcement actions should appear
in EPA's forthcoming final report. 66
F. Critique of the MWTA
It has been suggested that the MWTA was simply a
means by which Congress could temporarily stem constitu-
ents' demands for action in the wake of beach wash-ups, and,
with the dispersion of these political forces and the expiration
of the Act, the MWTA will have no material impact on the
problems of medical waste. 67 While this is not altogether
true, the demonstration program had certain weaknesses
which adversely affected its efficacy. For instance, the
MWTA did not address long-term risks associated with differ-
ent treatment and disposal systems, nor did it clearly enunci-
ate any preferred mode of disposal.' 68 While the MWTA
suggested that incineration may be the best mode of treat-
ment, it did not address problems surrounding medical waste
incinerators and it did not prompt EPA to establish basic pa-
rameters such as "air pollution emission standards, operating
temperatures and residence times for incinerators and auto-
claves, operator training and monitoring specifications, and
Tracking Act of 1988: An Analysis of its Provisions and its Effect on New York
State, 7 TouRo L. REV. 259 (1989-91).
164. EPA SECOND INTERIM REPORT, supra note 30, at 22.
165. Id.
166. See supra note 23.
167. PERSPECTrVES ON MEDICAL WASTE, supra note 17, at 31, wherein the
authors correctly predicted in 1989 that three policy debates would persist after
expiration of the MWTA: the level of danger inherent in infectious wastes,
what role EPA should play in their regulation, and the success of current prac-
tices in the handling and disposal of the waste.
168. Onel, supra note 10, at 240.
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ash disposal requirements." 16 9 Nor did the Act prohibit dis-
posal of medical waste through sewage systems.
The problem of beach wash-ups cannot be eradicated un-
til the underlying issues of waste disposal are confronted.
The MWTA placed no "restrictions on who could handle infec-
tious waste and where the waste should be treated and dis-
posed," and no minimal standards were set regarding
packaging and labeling, or the labeling and disinfection of
transport trucks.170 The Act was also unclear as to whether
incinerated waste was to be completely exempt from the
tracking system, or whether waste incinerated off-site was to
be tracked. 171 These uncertainties, including the small quan-
tity generator exemption, will influence the accuracy and
quality of the data EPA gathered under the MWTA and its
conclusions. Also, since there was no pre-MWTA baseline
data for comparison it is not clear if EPA will be able to ade-
quately interpret the information it gathers under the
MWTA.
While the MWTA permitted the EPA to grant implemen-
tation and enforcement authority, it did not address the issue
of compliance by haulers and disposal site operators. 172 Fur-
thermore, the stringent regulations imposed on the genera-
tors under the MWTA did not take into account varying risks
posed by different types of medical waste. The Act could have
been strengthened by imposing some of the tracking and han-
dling costs on the waste handlers. 73 In addition, the MWTA
did not address the interstate problem of medical waste, leav-
ing states to devise their own disparate regulations. Hence,
a "myriad of state responses has resulted in a standardless
national definition of infectious waste, and a complex array of
procedures and agencies intended to deal with the prob-
169. Id. The MWTA simply requires EPA to gather information, conduct as-
sessment studies and report to Congress.
170. Id. at 243.
171. Id.
172. Id. at 244.
173. Id. at 247.
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lem."'174 Finally, the program focused on northeastern states
with coastlines and beach wash-up problems; consequently,
the necessity or practicality of its transferability to other re-
gions is open to question. 175
In spite of its perceived shortcomings, the MWTA has
produced beneficial effects. It has contributed to our knowl-
edge of the medical waste stream and will help identify new
areas of concern. The program could help in the formulation
of a uniform definition of medical waste. In addition, enforce-
ment, inspection and tracking systems could serve as a future
model, even if Congress decides medical waste should be left
wholly within state purview.
According to EPA's preliminary evaluation of the MWTA,
the demonstration program has had several direct and indi-
rect effects. Its direct effects have been "the implementation
of a functioning tracking program and the collection of essen-
tial information."1 76 The indirect effects of the program in-
clude the encouragement of innovation in treatment
technologies such as gamma irradiation and microwaving
techniques, the reevaluation of home health care waste man-
agement, a possible reduction in the severity of beach wash-
ups, and a positive stimulus on medical waste program devel-
opment in noncovered states and foreign countries. 17 7 Since
enactment of the MWTA, nearly every state has passed some
type of medical waste legislation or revised its existing regu-
lations. 78 When EPA at last releases its final report to Con-
gress on the MWTA, the agency will make a recommendation
174. Scott Goldie, Blood on North American Soil: A Comparison of United
States and Canadian Infectious Waste Disposal Regulations, 16 SYRACUSE J.
INT'L L. & COM. 129, 158 (1989).
175. According to one commentary, the MWTA's scope, "was geographically
and temporally limited in order to increase its political feasibility .... By limit-
ing coverage to those geographical areas where public support was strongest,
and by limiting the authorized life of the program, the [Congress] could capital-
ize on public opinion without risking a battle with the health care establish-
ment." Nakamura et al., supra note 142, at 309. Thus, the MWTA could be
characterized as "an exercise in symbolic politics." Id. at 312.
176. EPA SECOND INTERIM REPORT, supra note 30, at 23.
177. Id. at 23-24.
178. EPA's final report to Congress is expected to address changes in the
covered states' program and provide further analysis of the indirect program
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on whether a continuing federal program is needed and if so,
what components the program should include. 179 Meanwhile,
management of medical waste in the United States is gov-
erned by an eclectic montage of statutes, rules, guidelines
and standards.
V. Current Federal Law Governing Medical Waste
A. The Resource Conservation and Recovery Act
EPA was given authority to regulate the handling, stor-
age, treatment, transportation and disposal of medical and
infectious waste in 1976 under Subtitle C of the Resource
Conservation and Recovery Act (RCRA),'5 0 which amended
the Solid Waste Disposal Act of 1965. RCRA represents Con-
gress's first attempt to control and regulate hazardous waste
from creation until disposal. Under RCRA, "hazardous
waste" is defined, in part, "a solid waste, or combination of
solid wastes, which because of its quantity, concentration,
physical, chemical or infectious characteristics may... pose a
substantial present or potential hazard to human health or
the environment when improperly treated, stored, trans-
ported, disposed of, or otherwise managed." 181 This defini-
tion appears to permit inclusion of infectious wastes among
the other RCRA-regulated hazardous wastes. In 1978, EPA
issued a preliminary rule that placed infectious waste in the
category of hazardous waste it proposed to regulate; however,
effects. Id. at 23. State regulation of medical waste is discussed infra at section
VI.
179. Id. at 2.
180. 42 U.S.C. § 6901-6992k (1988 & Supp. III 1991). The main outcome of
RCRA has been the creation of a stringent system for regulating hazardous
wastes. In practice, there is little federal regulation of other solid wastes such
as manufacturing wastes. See ENVIRONMENTAL AND ENERGY STUDY INSTITUTE,
EESI BRIEFING BOOK 55 (1993) at 55.
181. 42 U.S.C. § 6903(5) (1988) (emphasis added). EPA will regulate chemi-
cal waste only if it has a characteristic defined as hazardous, or is listed in 40
C.F.R. § 261 (1992). Generally, these lists pertain to toxic chemicals. Chemical
waste satisfying either condition will be legally identified as hazardous waste.
Some chemicals found in medical waste do exhibit at least one of these charac-
teristics, e.g., solvents are often ignitable. It is therefore possible for some in-
fectious wastes to be considered hazardous. See Reinhardt & Gordon, supra
note 149, at 140.
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when comment responses vociferously recommended against
regulation of infectious waste as hazardous, EPA decided not
to include infectious waste among the RCRA-regulated sub-
stances in the 1980 final rules.'8 2 With the release of the
rules in 1980, EPA said it would issue separate infectious
waste regulations; however, these have never appeared.' 8 3
Instead, EPA issued draft guidelines for infectious waste
management in 1982 and final guidelines in 1986.184
Under RCRA, the federal government's role is to provide
information, research and financial assistance to the states,
and to initiate a solid waste management policy. 185 Congress
put the federal government in this role to encourage states
and local governments to become active in implementing lo-
cal waste disposal programs while maintaining minimum na-
tional standards.' 8 6 The EPA has the authority to set
standards for hazardous waste handling, transportation 8
7
and storage, 88 and can enforce EPA regulations with civil
and criminal penalties. 8 9 However, EPA has chosen not to
regulate infectious waste as hazardous waste. With the expi-
ration of the MWTA, EPA is treating infectious waste as solid
waste, relying on the states to enforce their own infectious
waste programs. 190 As there are currently no regulations for
infectious waste management based on RCRA, EPA cannot
enforce any national standards for management and disposal,
182. PERSPECTIVES ON MEDICAL WASTE, supra note 17, at 3.
183. Id. at 3-4. EPA changed its position on the hazards presented by infec-
tious wastes and chose to make "recommendations" concerning their manage-
ment. Id.
184. EPA GUIDE, supra note 30, at vi. EPA's guide for infectious waste man-
agement satisfied RCRA's objective of providing information, but also contrib-
uted to the confusion surrounding the hazardousness of infectious waste by not
providing a basis for interstate control. Goldie, supra note 174, at 156-57. The
guide addresses problems posed by the infectious characteristics of medical
waste, but in so doing, contradicts EPA's original position that regulation of the
waste is not warranted because public risks were unproven. Id.
185. 42 U.S.C. § 6902(a) (1988).
186. 42 U.S.C. §§ 6901-02 (1988).
187. 42 U.S.C. § 6923 (1988).
188. 42 U.S.C. § 6924 (1988).
189. 42 U.S.C. § 6928 (1988).
190. Telephone interview with Ann Coggington, supra note 23.
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nor can it apply the penalties available under RCRA for infec-
tious waste mismanagement. 191
By granting EPA authority to regulate hazardous waste,
Congress presumably intended that EPA establish a national
standard for management of all forms of hazardous waste, in-
cluding, by definition, infectious waste. A national standard
would facilitate interstate regulation and control, and would
prevent conflicts of policy and enforcement between neighbor-
ing states. Moreover, classifying infectious wastes as hazard-
ous could be desirable from the standpoint that it would allow
prosecution of illegal dumping as a felony and permit more
stringent treatment of violations. Additionally, it would per-
mit tracking of infectious wastes from generation to disposal
or destruction, and would thereby ensure greater comprehen-
sive management of infectious wastes. On the other hand,
treating infectious waste as hazardous waste under RCRA
Subtitle C will likely increase the costs of management and
disposal, create further difficulty in siting disposal facilities,
impose burdensome requirements on generators, handlers
and transporters, and shift non-health care costs to patients.
The foregoing factors must be weighed in the balance while
recognizing that the risk associated with medical waste is
still vigorously debated. Legislative action has been proposed
as a means of addressing the issue.
In the 102nd Congress one proposed bill amending RCRA
was introduced on April 25, 1991 by Senator Max Baucus. 192
It specifically addressed medical waste and provided, among
other things, that the EPA Administrator define medical
waste in consultation with the Director of the Centers for Dis-
ease Control, the Assistant Secretary of Labor for Occupa-
tional Safety and Health, the Commissioner of the Food and
191. See Goldie, supra note 157, at 147-48.
192. S. 976, 102d Cong. 1st Sess. (1991). The bill was intended to eliminate
use of certain hazardous substances and reduce production of wastes by di-
recting EPA to address toxic use and source reduction. In addition, the bill also
addressed municipal waste recycling, waste treatment, containment and incin-
eration. The bill was strongly opposed by industry because of its toxic reduction
provisions, and eventually floundered, never reaching a vote in the Senate. "A
Tale of Sound and Fury: The Environmental Record of the 102d Congress," 23
ENVTL. L. REP. 10,015, 10,020 (Envtl. L. Inst.) (Jan. 1993).
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Drug Administration and the Secretary of Transportation. 193
In addition, the amendment set standards for medical waste
storage and containment, provided treatment options to de-
stroy or sterilize infectious agents or render them unrecogniz-
able, and established transportation requirements including
a tracking form maintained by a registered transporter. 194
None of the legislation addressing medical waste proposed in
the 102nd Congress passed. Currently, there is no legislation
pending in the 103rd Congress specifically addressing man-
agement of medical waste and RCRA reauthorization this
term appears unlikely. 95
B. The Clean Water Act
Both the Clean Water Act (CWA)1 96 and the Marine Pro-
tection, Research and Sanctuaries Act (MPRSA) 9 7 regulate
discharge and disposal of medical waste. These two statutes
193. S. REP. No. 301, 102d Cong. 2nd Sess. at 60 (1992).
194. Id. at 61. The section amending RCRA was "designed to assure that a
minimum national system for the management of medical wastes is put in
place." Id. The House RCRA reauthorization bill, H.R. 3865, was introduced on
November 22, 1991 as "The National Waste Reduction, Recycling and Manage-
ment Act," however, it never passed. See H.R. REP. No. 102-839, 102d Cong. 2d
Sess. (1992). Legislation such as S. 1083 was proposed to extend the MWTA
and was approved by the Senate, but no corresponding action was taken by the
House of Representatives. See S. REP. No. 103-33, 103rd Cong., 1st Sess. 12
(1993).
195. Much of the pending proposed legislation addressing solid waste con-
cerns interstate transportation and disposal of waste and waste incineration.
See, e.g., H.R. 963, H.R. 1076, H.R. 2488, S. 439, S. 822 and S. 424. Numerous
states have enacted statutes to prohibit or restrict imports of solid waste from
other states, but courts have struck down several of the laws as unconstitu-
tional because they interfere with interstate commerce. Local opposition to dis-
posal of out-of-state waste has prompted some members of Congress to seek
legislation giving states and localities authority to restrict importation of medi-
cal waste. EESI BRIEFING BooK, supra note 4, at 55. Also, for a list of recent
cases addressing interstate transportation of waste, see "A Tale of Sound and
Fury," supra note 192, n.133. Superfund reauthorization seems to have a
higher priority than RCRA reauthorization in the 103rd Congress, and it ap-
pears RCRA is not likely to be addressed this Congressional session; conse-
quently, it is unknown whether RCRA will specifically address medical waste in
the future. See 23 Env't Rep. (BNA) 3108 (Apr. 9, 1993) and 23 Env't Rep. [Cur-
rent Development] (BNA) 681 (Jun. 19, 1992).
196. 33 U.S.C. §§ 1251-1387 (1988 & Supp. IV 1992).
197. 33 U.S.C. §§ 1401-1445 (1988 & Supp. IV 1992).
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not only protect surface water from degradation from im-
proper medical waste disposal, but they may also prevent
beach wash-ups and closings, which are occurring with more
frequency. 198 Most beach closings are caused by beach pollu-
tion from combined sewer overflows, polluted runoff, raw
sewage overflow, overloaded sewage treatment plants, septic
tank pollution and boating wastes. 199 How much improper
medical waste disposal contributes to beach closings every
year is unknown. Nevertheless, recent history confirms that
medical waste pollution is a significant factor. Questions re-
main whether the CWA and the MPRSA can be used to con-
front it.
The CWA makes it an offense for any person to discharge
a pollutant into navigable waters from a point source. 200
However, in the context of medical waste disposal, the defini-
tion of "point source" has been subject to conflicting interpre-
tations. For instance, in U.S. v. Villegas, a doctor was
originally convicted of being a point source when he unlaw-
198. In its third annual report on beach closings, the Natural Resources De-
fense Council (NRDC) found that there were more than 2,600 beach closings or
advisories in 1992, which was higher than 1991 figures. NRDC, Testing the
Waters III: Closings, Costs, and Cleanup at U.S. Beaches, NRDC Report, 3
(June 1993). This data contradicts EPA's assertion that one beneficial effect of
the MWTA was reduced beach closings.
199. Id. at 9. See also Michael Specter, Sea-Dumping Ban: Good Politics,
But Not Necessarily Good Policy, N.Y. TIMES, Mar. 22, 1993, at Al, for a discus-
sion of ocean dumping and medical waste wash-ups. The author maintains that
wash-ups were primarily due to combined sewer overflows in New York and
New Jersey and that ocean dumping was unrelated to the beach wash-ups and
closings. Commenting on the Ocean Dumping Ban Act, he states that the legis-
lation "is a striking triumph of environmental politics over science, a clear dem-
onstration of how environmental policy can often be directed by symbols and
fears [rather] than by reasoned discussion of benefit and risk." Id.
200. 33 U.S.C. § 1311(a) (1988). A point source is defined in § 1362(14) as
'any discernible, confined and discrete conveyance, including but not limited to
any pipe, ditch, channel, tunnel, conduit, well, discrete fissure, container, roll-
ing stock, concentrated animal feeding operation, or vessel or other floating
craft, from which pollutants are or may be discharged. The term does not in-
clude agricultural stormwater discharges and return flows from irrigated agri-
culture." 33 U.S.C. § 1362(14) (1988). Congress defined "the discharge of a
pollutant" as "any addition of any pollutant to navigable waters from any point
source. . . ." 33 U.S.C. § 1362(12) (1988). The broad definition of "pollutant"
includes dredged spoil, solid waste, incinerator residue, sewage, garbage, chem-
ical wastes, and biological materials. Id. at § 1362(6).
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fully disposed of vials of blood by wedging them into the rocks
of a river bulkhead.20 1 School children visiting the nearby
beach found some of the glass vials laying in the sand and
tests revealed that five of the vials contained blood infected
with hepatitis B, an infectious virus that causes inflamma-
tion of the liver.20 2 In its initial opinion the United States
District Court found that Congress intended an expansive
reading of the term "point source," and did not exclude a per-
son from within its meaning since the object of a CWA inquiry
is whether a defendant's activity deliberately threatened the
"chemical, physical and biological integrity of the Nation's
waters."203 However, the case was reversed on appeal and
the United States Circuit Court specifically addressed the
question whether a human being can be a point source.20 4
The appeals court found that human beings are not among
the enumerated items that may be a "point source" and that
the CWA generally targets industrial and municipal sources
of pollutants. 205 According to the court, "this statute was
never designed to address the random, individual polluter
like Villegas."20 6 This ruling raises some unanswered ques-
tions about how effectively the CWA can be used addressing
unlawful handling and disposal of medical waste.
The CWA's sister statute, the MPRSA may be useful in
protecting the ocean from illegal dumping of medical waste.
Popularly known as the Ocean Dumping Act or the Ocean
Dumping Ban Act, the purpose of the MPRSA is "to regulate
the dumping of all types of materials into ocean waters and to
prevent or strictly limit the dumping into ocean waters of any
material which would adversely affect human health, wel-
fare, or amenities, or the marine environment, ecological sys-
tems or economic potentialities."20 7 Specifically, the Act
regulates the transportation of material from the United
201. 784 F. Supp. 6 (E.D.N.Y. 1991).
202. Id.
203. 784 F. Supp. at 10 (quoting 33 U.S.C. § 1251(aX1988)).
204. 3 F.3d 643 (Cir. 2 1993).
205. Id. at 646.
206. Id.
207. 33 U.S.C. § 1401 (1988 & Supp. IV 1992).
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States to a location outside the country for the purpose of
dumping it into the ocean, and the dumping of material
transported by anyone from a location outside the United
States if the dumping occurs in the territorial sea or contigu-
ous zone of the United States.208 Among other things, the Act
establishes a permit program for the transportation and
dumping of material into ocean waters, and only allows per-
mits for three distinct activities: (1) transportation of any ma-
terial from the United States for the purpose of dumping it
into ocean waters; (2) dumping of any material transported
from outside the United States into the territorial sea of the
U.S. or the contiguous zone; (3) transporting any material by
a United States agency or United States registered vessel
from outside the U.S. for the purpose of dumping it into ocean
waters. 20 9 The term "material" is broadly defined in the Act
and includes chemicals, biological and laboratory waste, and
"other waste."210 Medical waste is specifically addressed
under the MPRSA and is discreetly defined.211 The Act pro-
hibits ocean dumping of medical waste, radiological, chemi-
cal, and biological warfare agents, and radioactive waste.21 2
For each violation, civil penalties of up to $50,000 can be
assessed for violating the Act, its implementing regulations,
or a permit.213 In addition, any person who violates the Act
by "engaging in activity involving the dumping of medical
waste" is liable for a civil penalty of up to $125,000 for each
208. 33 U.S.C. § 1401(c) (1988 & Supp. IV 1992).
209. 33 U.S.C. § 1412 (1988 & Supp. IV 1992).
210. 33 U.S.C. § 1402(c) (1988).
211. According to the Act's definitions, medical waste includes isolation
wastes, infectious agents, human blood and blood products, pathological
wastes, sharps, body parts, contaminated bedding, surgical wastes and poten-
tially contaminated laboratory wastes, dialysis wastes, and additional items
prescribed by regulation. 33 U.S.C. § 1402(6) (1988).
212. 33 U.S.C. § 1412(a) (1988 & Supp. IV 1992). Relevant Congressional
oversight hearings include Hearings Before the Subcommittee on Fisheries and
Wildlife Conservation of the House Committee on Merchant Marine and Fisher-
ies 100th Cong., 2d Sess. (1988) on the closure of coastal areas due to medical
waste and sewage contamination, and Hearing Before the Subcommittee on Oce-
anography of the House Committee on Merchant Marine and Fisheries, 100th
Cong., 2d Sess. (1988) on H.R. 3478, a proposed bill to amend the MPRSA and
the CWA.
213. 33 U.S.C. § 1415 (1988).
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violation.214 A knowing violation can result in criminal pen-
alties of up to $50,000 or imprisonment for one year, or both,
and knowingly engaging in activity involving dumping medi-
cal waste into ocean waters can result in a $250,000 fine or
imprisonment for up to 5 years, or both.215
C. The Clean Air Act
The Clean Air Act addresses one significant aspect of
medical waste: incineration. 216  Historically, incineration
was the only method of treatment accepted by regulators for
infectious waste because it offers total destruction, providing
an aesthetic benefit and reducing solid waste disposal cost.21 7
In addition, when incinerators are outfitted with heat recov-
ery capability, they can provide a reduction in the medical
waste generator's energy cost by using heat from the inciner-
ator to fire boilers. 218 Other advantages of incineration are
that it requires little processing of wastes before burning and
can often be done on-site. 219 The main disadvantages are the
high cost and the potential pollution risks associated with in-
cineration processes.220 Pollutants of concern from medical
waste incinerators include particulate matter, toxic metals,
214. Id.
215. Id.
216. Clean Air Act, 42 U.S.C. §§ 7401-7671q (1988 & Supp. III 1992). "Incin-
eration is the process by which combustible materials are burned, producing
combustion gases and noncombustible residue and ash." U.S.E.P.A., OPERA-
TION AND MAINTENANCE OF HOSPITAL MEDICAL WASTE INCINERATORS, at 2.1
(1990) (hereinafter EPA INCINERATION HANDBOOK).
217. Deborah Jessup, INFECTIOUS WASTE: THE COMPLETE RESOURCE GUIDE,
1988, E-63, containing testimony of Robert B. Shaw, Vice President, BFI Medi-
cal Waste Systems, Inc. "Incineration sterilizes and detoxifies medical waste
and converts it to ash, reducing its weight and volume by 90 to 95 percent."
Floyd Hasselris & Laura Constantine, Characterization of Today's Medical
Waste, in MEDICAL WASTE INCINERATION AND POLLUTION PREVENTION, supra
note 59 at 37.
218. Green, supra note 59, at 37.
219. OTA BACKGROUND PAPER, supra note 2, at 15.
220. Id. According to EPA, "[r]eduction of atmospheric emissions of constitu-
ents that are potentially harmful to human health and the environment is a
prerequisite to acceptance of hospital incineration as a feasible disposal alter-
native by the community." EPA INCINERATION HANDBOOK, supra note 216, at
2.1. A recent study confirmed the increasing use of hospital disposable products
and identified numerous ways of reducing medical waste through substitution,
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toxic organics, carbon monoxide, and acid gases such as hy-
drogen chloride, sulfur dioxide and nitrous oxides. 22 1 The is-
sue of risk posed by incineration byproducts is under debate.
A recent study found that measured background levels of con-
taminants posed significantly higher risks to people than in-
cremental additional discharges of pollutants linked to
incinerators in the New York and New Jersey metropolitan
area.222 According to the study, hospital infectious waste in-
cinerators were associated with the smallest potential health
impacts of all evaluated source categories, whereas municipal
solid waste incinerators were associated with the greatest po-
tential health impact.223 As the debate over health risks in-
tensifies, states are more aggressively regulating medical
waste incinerators. For example, California had proposed
regulations on new and existing medical waste incinerators
that were expected to result in the shutdown of 90% of the
state's incinerators because of the high cost of retrofitting air
pollution control systems to control dioxin and metals. 224 At-
minimization and recycling of certain disposable products. Disposable Products
in the Hospital Waste Stream, 268 JAMA 2508 (Nov. 11, 1992).
221. EPA INCINERATION HANDBOOK, supra note 216, at 3.1. For example, hy-
drochloric acid and chlorine are released from the burning of plastics in gener-
ally ill-equipped hospital incinerators. Diane Levetan, Medical Waste Disposal:
A Growing American Crisis, Am. CITY & CouNTY, May 1990 at 68. For a discus-
sion of the economic impact of incinerator emission regulation, state initiatives,
and the growth in alternative treatment technologies, see Rubin, supra note 8,
at 26.
222. Incineration 2000: Phase II Report, cited in MED. WASTE NEWS, Apr. 12,
1993, at 15.
223. Id. By comparison, a study for the Florida Department of Environmen-
tal Regulation (FDER) found that municipal solid waste incinerators and medi-
cal waste incinerators combined account for 29 percent of all Florida mercury
air pollution. The FDER wants the state to legislatively ban mercury for medi-
cal uses where possible. Florida DER Finds MSW, Medical Incinerators Caus-
ing 29% of Mercury Pollution, HAz. WASTE Bus., Feb. 24, 1993, at 20.
224. Lee, supra note 50 at 360. In Texas v. National Medical Waste of Texas
Inc., Tex. Dist. Ct. 239th Jud. Dist., No. 91G2902, (Aug. 3, 1992), a corporate
defendant which disposed of human body parts and other medical waste agreed
to pay $110,000 in civil penalties. The amount was in partial settlement of a
lawsuit alleging the company violated the Texas Clean Air Act and the rules
and regulations of the Texas Air Control Board by surpassing opacity limits,
failing to complete stack testing requirements, and exceeding emission limits
for pollutants including oxides of nitrogen, carbon monoxide and hydrogen
chloride.
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tempting to avoid costs associated with incineration and its
increased regulation, some hospitals are seeking alternative
methods of treatment such as microwaving. 225 For instance,
a new treatment and disposal method called "electrical ther-
mal deactivation" uses high-energy radio waves to cook the
medical waste without producing ash or fumes.
226
The total amount of medical waste incinerated per year
is unknown; however, it remains the most prevalent form of
infectious waste treatment. 227 Today, incineration accounts
for more than 75 percent of the total medical waste treated,
while most of the remaining medical waste is autoclaved.225
The Clean Air Act Amendments of 1990 specifically address
solid waste combustion, and because medical waste is cur-
rently considered solid waste, it is covered by the statute.
Section 129 of the Clean Air Act Amendments of 1990
requires EPA to develop new source performance standards
(NSPS) and emission guidelines (EGs) for four classes of solid
waste incineration units: municipal waste combustors, medi-
cal waste incinerators, industrial and commercial waste in-
cinerators and categories of other solid waste incinerators. 229
225. In May 1992, a consortium of eighteen Minneapolis and St. Paul hospi-
tals and a coalition of environmental and medical groups agreed to treat some
of their combined annual 3,000,000 pounds of infectious waste with steam and
microwaves instead of incinerating it. Only a relatively small portion of infec-
tious waste will still be incinerated (pathological waste, e.g. human tissue).
Environmental advantages to these methods of disposal include a reduction in
toxic air pollutants (no emission permits are necessary), and the ability to dis-
pose of the residual waste in regular landfills. 23 Env't. Rep. [Current Devel-
opments] (BNA) 408 (May 22, 1992). An increase in these methods of treatment
and disposal are but two of the current trends in the waste disposal market.
Others include a corresponding decrease in incineration, industry consolida-
tion, and stabilization of supply versus demand. 23 Env't. Rep. [Current Devel-
opments] (BNA) 282 (May 8, 1992).
226. Scott McFetridge, We Really Want Your Medical Waste, GARBAGE, July
1993, at 19.
227. EPA estimated that the total amount of hospital waste incinerated,
when including the waste incinerated off-site, is about 80 percent of the total
hospital waste in the United States. OTA BACKGROUND PAPER, supra note 2, at
15 n.1.
228. Malloy, supra note 6, at 67.
229. 42 U.S.C § 7429(a) (1988 & Supp. III 1992). EPA's Administrator estab-
lishes performance standards for each category of solid waste incineration
units. Id. New source performance standards are the minimum federal emis-
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Under section 129, EPA must establish numerical limits for
emissions of acid gases (sulfur dioxide and hydrogen chlo-
ride), particulate matter, opacity, metals (cadmium, lead, and
mercury), organics (dioxins/furans), carbon monoxide, and ni-
trogen oxides from solid waste incineration units.230 The
agency has issued a list of the types of incinerators to be in-
cluded under the category of "other solid waste incinerators"
(OSWIs) and the scheduled date for promulgating NSPS and
EGs for OSWIs is November 15, 2000.231 New source per-
formance standards and emission guidelines for other types
of incinerators, including medical waste incinerators, are to
be developed under separate rulemaking actions. 232
EPA's notice of proposed rulemaking on medical waste
incinerators was delayed, ostensibly because of budget cut-
backs and internal EPA disagreements regarding monitoring
issues.233 The proposed rule will develop NSPS and EGs for
existing sources enforced under Sections 111 and 129 of the
Clean Air Act, and it is likely that states will have to submit
plans for implementing and enforcing the guidelines.234 Be-
cause mandatory monitoring devices can be costly, EPA is
grappling with questions about how to monitor compliance;
furthermore, the agency is trying to reach an internal consen-
sus on whether pollution control technology or monitoring
should be foremost on the agency's agenda. 235
The other debate surrounding medical waste incinera-
tion is whether or not the ash produced is hazardous. EPA
decided in September 1992 that municipal solid waste ash
sions limits set by EPA for all new or substantially modified sources of air pollu-
tion in major polluting industries. The standards are based on the best
technology currently available, taking costs into account. See 42 U.S.C. § 7429
and EESI BRIEFING BOOK, supra note 4, at 13.
230. 42 U.S.C. § 7429 (1988 & Supp. III 1991). Solid waste incineration unit
is defined at § 7429(g)(1).
231. 58 Fed. Reg. 31,358-59 (1993).
232. Id.
233. The latest notice deadline for medical waste incinerators was March
1994, moved back from October 1993. Final action is scheduled to take effect in
August 1995. See EPA Medical Waste Incinerator Rule Stuck on Monitoring
Issue, MED. WASTE NEWS, May 12, 1993, at 8.
234. Id.
235. Id.
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should fall under RCRA's household waste exclusion and
thus be treated as nonhazardous. 236 However, two divergent
Circuit Courts of Appeals rulings on this issue have emerged.
The United States Circuit Court of Appeals for the Second
Circuit excluded municipal solid waste ash from considera-
tion as a hazardous waste,237 while the Seventh Circuit ruled
that the ash is subject to regulation as a hazardous waste.238
The Supreme Court upheld the Seventh Circuit, ruling that
RCRA Section 3001(i) does not exempt the municipal waste
combustion ash generated by the petitioner, City of Chicago,
from regulation under RCRA Subtitle C as hazardous
waste.239 Notably, the Court pointed out the petitioners'
waste stream was not solely household waste, but consisted
of combined household waste and nonhazardous industrial
waste, and the Court was not willing to extend the Section
3001(i) exemption to such a waste stream. 240 It is presently
unclear how broad an impact this ruling will have. 241
236. This RCRA exclusion states that a municipal resource recovery facility
is not deemed to be "treating, storing, disposing of, or otherwise managing" haz-
ardous waste if it receives and burns only household waste. 42 U.S.C. § 6921(i)
(1988 & Supp. III 1991).
237. Environmental Defense Fund v. Wheelabrator Technologies, 931 F.2d
211 (2d Cir. 1991).
238. Environmental Defense Fund v. Chicago, 948 F.2d 345 (7th Cir. 1991)
cert. granted, 61 U.S.L.W. 3851 (U.S. Jun. 21, 1993) (No. 92-1639). The
Supreme Court originally remanded the case for consideration in light of a Sep-
tember 1992 EPA memorandum explaining the Agency had changed its position
to include municipal incinerator ash within the section 6921(i) exclusion. The
7th Circuit stated that the Agency had changed its view so frequently that it
was no longer entitled to the deference normally accorded an Agency's interpre-
tation of the statute it administers. 948 F.2d at 346. The question presented to
the Supreme Court was whether section 6921(i) of RCRA, "which provides that
[a] resource recovery facility recovering energy from the mass burning of munic-
ipal solid waste shall not be deemed to be treating, storing, disposing of, or
otherwise managing hazardous wastes, exempt[s] from hazardous waste regu-
lation ash generated by burning municipal solid waste at such facility?" 61
U.S.L.W. 3779 (May 15, 1993).
239. City of Chicago v. Environmental Defense Fund, 62 U.S.L.W. 4283
(May 2, 1994).
240. Id.
241. Id. In his dissent, Justice Stevens concedes that the majority's decision
may represent sound policy because requiring cities to spend funds to dispose of
incinerator residues in accordance with Subtitle C will provide additional pro-
tection to the environment. Nevertheless, he questions the decision's impact on
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VI. State Regulation of Medical Waste
The Medical Waste Tracking Act (MWTA) was enacted
by Congress amid concern about the inconsistent regulation
of medical waste among the states and local municipali-
ties. 242 State and local laws ranged from comprehensive stat-
utes to a total absence of regulation. Congress's assessment
of local regulation also concluded that an overarching federal
regulatory scheme was necessary to effectively control the in-
terstate transportation and disposal of medical waste.243
In enacting the MWTA, Congress charged EPA with the
responsibility to study existing state and local controls on the
handling, storage, transportation, treatment, and disposal of
medical waste, including enforcement and regulatory super-
vision.244 EPA responded by creating a demonstration track-
ing and management program which collects information on
existing medical waste requirements for the five areas cov-
ered by the program. EPA is also studying current and pro-
posed medical waste regulations in the states that "opted out"
of the demonstration program.245 The objective of EPA's
analysis is to examine what makes a successful medical
waste management program by comparing the programs and
compiling a list of the most important factors such as track-
ing, packaging, disposal methods, and comprehensiveness of
medical waste definition. The Agency will publish the results
of its study in its third and final report to Congress.246
scarce landfill space and on the policy of encouraging resource recovery. More-
over, it is questionable, he asserts, whether the environmental benefits of this
decision justify the costs of additional regulation.
242. EPA SECOND INTERIM REPORT, supra note 30, at 4. See also, Health
Hazards Posed in the Generation, Handling and Disposal of Infectious Wastes:
Hearing Before the Subcommittee on Regulation and Business Opportunities of
the House Committee on Small Business, 100th Cong., 2d Sess. (1988); Medical
Waste and Sewage Contamination: Hearing Before the Subcommittee on Fisher-
ies and Wildlife Conservation of the Committee on Merchant Marine and Fisher-
ies, 100th Cong., 2d Sess. (1988).
243. EPA SECOND INTERIM REPORT, supra note 30, at 4.
244. 42 U.S.C. § 6992g (1988).
245. EPA FiRsT INTERIM REPORT, supra note 4, ch. 8; EPA SECOND INTERIM
REPORT, supra note 30, at 40.
246. Id. EPA is collecting state information related to several key areas: the
nature of the state medical waste program (regulatory or nonregulatory); the
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States began acknowledging medical waste as a distinct
waste stream in need of regulation around 1988. In 1986
only 57 percent of the states had infectious waste regulations
or bills pending.247 By 1989, around 84 percent of all states
had bills pending, regulations promulgated or recommenda-
tions made on proper disposal of medical waste.248 A survey
of state laws reveals that some form of medical waste regula-
tion exists in nearly every state except Wyoming, which has
issued general, nonbinding guidelines. 249 As Congress found
earlier, the state laws existing today differ significantly in
terminology, scope and controls imposed. Those who are sub-
ject to medical waste regulation may find it difficult to attain
full compliance with the variety of statutory schemes in exist-
ence. 250 Obviously, the variation in regulatory stringency
can lead to forum shopping where generators search for the
least expensive and least stringent state in which to dispose
of their waste.251 Because of the varied state regulation, a
generator must examine the laws of the state where treat-
ment and disposal occur, as well as the laws of every state
through which its waste travels. States enacting prohibitions
or moratoriums on the issuance of permits for medical incin-
erators complicate this problem, as does the often strident
public opposition to siting of medical waste disposal and
treatment facilities. 252 In addition, local governments like
counties and municipalities issue local regulations or "ordi-
nances" and "codes" which restrict medical waste manage-
state's treatment of the home health care sector (inclusion or exclusion); and
the scope of the state programs. Id.
247. Shell J. Bleiweiss & Janice M. Edwards, A Cure for What Ails Us? En-
vironmental Regulation of the Medical Industry, 6 Envtl. F. 7 (1989).
248. See Shumaker, supra note 117, at 556.
249. WASTE AGE, supra note 6, at 75.
250. Coon & Gilberg, supra note 137, at 1114.
251. This issue has received increasing attention recently as evidenced by
the proposed legislation on interstate transportation of waste. See supra note
195.
252. Coon & Gilberg, supra note 137, at 1100. In its state medical waste
survey of 1992, NSWMA's WASTE AGE/INFECTIOUS WASTES NEWS found that
nine states had current moratoriums on new commercial incinerators. Nearly
all states reported they were planning more regulatory action. WASTE AGE,
supra note 6, at 74. See also Goldie, supra note 174, at 129-34.
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ment. For instance, local ordinances may specify which types
of waste may not be deposited in the local landfill or burned
in the county incinerator. These ordinances may also define
medical waste in their own way, adding further to the confu-
sion surrounding medical waste handling.
State and local regulations which impact the interstate
movement of waste, including medical waste, are a contempo-
rary subject of judicial interpretation and legislation.25 3 Ju-
dicial disputes frequently arise in the context of a local or
state ordinance which prohibits or regulates non-local waste
differently than local waste. In Fort Gratiot Landfill v. Mich-
igan Department of Natural Resources, the Supreme Court
held that an ordinance which regulates imported waste dif-
ferently from local waste unambiguously discriminates
against interstate commerce. 25 4 When a county ordinance or
regulation treats out-of-county wastes differently than local
waste, the county bears the burden of showing there is some
reason, apart from waste origin, for the unequal treatment.
Indeed, the county or state must justify the discrimination
with facts "unrelated to economic protectionism."255 In a re-
cent case involving medical waste, the Ninth Circuit upheld a
district court ruling that a Washington county ordinance,
which banned importation of infectious medical waste from
outside counties, violated the Commerce Clause because it
discriminated against interstate commerce. The county also
failed to support its claim that the ordinance was a means of
protecting county residents from risks associated with medi-
cal waste. The court found that the county did not demon-
strate that out-of-county medical waste was more hazardous
than local medical waste.256
253. See supra note 195.
254. 112 S. Ct. 2019 (1992). See also Diamond Waste, Inc. v. Monroe County,
796 F. Supp. 1511 (M.D. Ga. 1992), summ.j. granted, 828 F. Supp. 52 (M.D. Ga.
1993).
255. New Energy Co. of Indiana v. Limbach, 486 U.S. 269, 274 (1988); Chem-
ical Waste Management, Inc. v. Hunt, 112 S. Ct. 2009 (1992).
256. BFI Medical Waste Systems v. Whatcom County, 983 F.2d 911 (9th Cir.
1992).
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Because medical waste is disparately regulated at many
levels, some argue the need for at least minimum federal reg-
ulation of the field. One commentator has opined:
The standardless national definition of infectious waste
has lead to a myriad of state responses and a complex ar-
ray of procedures and agencies intended to deal with the
problem at the state level. Neighboring state's [sic] infec-
tious waste policies often clash and contribute to each
other's failures. State regulatory measures that require
records proving waste delivery to certified disposal sites
are confounded by delivery to sites out of state and their
inability to track the waste across state lines .... Without
a consistent basis for state regulatory behavior and en-
forcement, interstate waste conflicts and illegal dumpings
will continue to be a problem. 257
Many existing state programs are similar to the federal
MWTA program. Surveys of state medical waste laws and
regulations reveal that their prominent features include a
definition of medical/infectious waste; requirements for stor-
ing, handling, packaging and shipping medical waste; a medi-
cal waste tracking or manifest system; regulations on the
treatment of medical waste; and enforcement provisions. 258
In attempting to define the universe of regulated medical/in-
fectious wastes, states have drawn from both the EPA guide-
lines, the MWTA and the CDC guidelines. These definitions
may even vary within the state statutes, depending upon the
statute's enactment date, the significance of more recent revi-
sions, and the specific chapter of state law.259 Additionally,
in developing medical waste programs, some states followed
guidelines provided by the Council of State Governments
which detail the components of a medical waste management
plan.260
257. Goldie, supra note 174, at 32-33 (footnotes omitted).
258. See Shumaker, supra note 117, and statutes cited therein.
259. Goldie, supra note 174, at 136.
260. COUNCIL OF STATE GOVERNMENTS, MODEL GUIDELINES FOR STATE MEDI-
CAL WASTE MANAGEMENT, (1992). The Council's Center for Environment pre-
pared the guidelines pursuant to a grant from EPA's Office of Solid Waste. The
guidelines are EPA's response to the MWTA's requirement that the Agency
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States which promulgate their own infectious waste pro-
grams in lieu of federal programs are first required to submit
to EPA written applications for authorization of such pro-
grams.261 In order to receive authorization, states must show
that their programs are equivalent to the federal program.
As infectious wastes are not deemed hazardous under the
federal program, equivalency generally is interpreted to
mean that the states do not have to regulate these wastes as
hazardous. 262 There are four main arguments against regu-
lating infectious waste as hazardous waste:
(1) [t]he public might inaccurately perceive that medical
wastes present the same severity and duration of risk that
hazardous wastes present;
(2) [i]nsurance premiums may become artificially high if
underwriters perceive regulated medical [sic] wastes to
present the same risks as hazardous chemical wastes;
(3) [t]he presence of medical waste could be construed as
contributing to environmental damage and therefore be
subject to the regulations and restrictions of the Compre-
hensive Environmental Response, Compensation, and Lia-
bility Act (CERCLA); and
(4) [r]egulatory, economic, and liability restrictions might
be placed on the ultimate treatment and disposal of regu-
lated medical waste precluding on-site [sic] treatment by
health facilities.263
EPA's infectious waste management guide offers recom-
mendations for state regulatory programs.264 However, these
recommendations are guidelines only, and do not require
states to mirror the EPA guide in order to create an
"equivalent" regulatory program.265 Since no consistent,
identify alternative, i.e., nonregulatory approaches to medical waste
management.
261. 42 U.S.C. § 6926 (1988).
262. OTA BACKGROUND PAPER, supra note 2, at 8.
263. AD Hoc COMMITTEE ON MEDICAL WASTE AND HAZARDOUS MATERIALS,
AMERICAN HOSPITAL ASSOCIATION, SHAPING STATE AND LOCAL REGULATION OF
MEDICAL WASTE AND HAZARDOUS MATERIALS 4 (May 1990).
264. 42 U.S.C. § 6926 (1988).
265. EPA GUIDE, supra note 30, at 1-1.
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binding federal medical waste regulations exist, states have
independently enacted and enforced their own policies.
There is little specific EPA direction as to how states should
enforce their policies or how they may qualify for federal
funds to initiate a program.266 Consequently, states have re-
lied entirely on their own agencies and the result has been a
variety of methods for dealing with medical waste.
States generally enforce their infectious waste regula-
tions through different state departments and bureaus such
as the department of health and departments of environmen-
tal protection or environmental health. Lack of enforcement
in neighboring states is one of the greatest problems facing
some states in enforcing their infectious waste regulations. 267
Without national standards, these disparities will continue.
The Office of Technology Assessment recommended to
Congress:
A more comprehensive approach to medical waste man-
agement, one consistent with the broader waste manage-
ment strategy evolving nationally, could be formally
established if the issue of medical waste remains part of
the current RCRA reauthorization effort. Medical wastes
need to be put into a broader frame of reference along with
other wastes (e.g. municipal and industrial hazardous and
nonhazardous wastes) if we are to establish appropriate
levels of protection for humans and the environment. 268
VII. Miscellaneous Federal Regulations, Guidelines,
Policies, and Work Practice Standards
Regulations, guidelines, standards and policies prolifer-
ate in the medical waste arena. Regulations are the most
stringent. They normally are issued by governments at the
federal, state and local levels; their requirements are
mandatory, enforceable by law, and penalties can be assessed
for noncompliance. By comparison, guidelines usually are is-
266. Goldie, supra note 174, at 148, and notes cited therein.
267. Id. at 150.
268. OTA REPORT, supra note 3, at 9.
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sued by government or professional organizations and com-
pliance usually is voluntary. Standards often are set by
professional organizations such as the Joint Commission on
the Accreditation of Health Care Organizations (JCAHO),
and although these guidelines may not always be enforceable
at law, some types of certification are dependent upon meet-
ing the standards. 269 In addition, private organizations such
as the American Hospital Association (AHA) and the Na-
tional Safety Council (NSC) also develop recommendations
and provide materials and assistance to organizations and
agencies developing standards and regulations for medical
waste management. On the "regulatory" continuum, policies
are the least persuasive of all authority and generally set
forth a broad statement of intent.
A. Occupational Safety and Health Administration
Regulations
The Occupational Safety and Health Administration
(OSHA) of the United States Department of Labor was estab-
lished by the Occupational Safety and Health Act of 1970,
and is responsible for ensuring safe and healthy working con-
ditions for United States workers. 270 OSHA's principal func-
tion is to promulgate and enforce workplace safety and health
standards. In addition to federal OSHA regulations, some
states have their own OSHA programs approved under Sec-
tion 18 of the Act.271
269. REINHARDT & GORDON, supra note 149, at 19.
270. 29 U.S.C. §§ 651-673 (1988). The OSHA regulations are contained in
Title 29 of the Code of Federal Regulations. The Act authorizes the National
Institute for Occupational Safety and Health (NIOSH) to develop and establish
recommended occupational safety and health standards, and to conduct re-
search and experimental programs to develop criteria for new standards. NI-
OSH is also authorized to investigate specific workplace hazards in response to
requests by workers or employers. Although NIOSH has the same right of en-
try as OSHA to conduct health hazard inspections and evaluations, NIOSH can
only recommend hazard controls and has no enforcement authority.
271. The Occupational Safety and Health Act requires OSHA to encourage
states to develop and operate their own workplace and safety and health pro-
grams which must be at least as stringent at the federal program. Id. A state
plan may be approved by OSHA if the state demonstrates that within three
years it will meet all the steps necessary to become at least as effective as the
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REGULATION OF MEDICAL WASTE
There are generally four OSHA standards which address
infectious waste issues in the workplace. The first is OSHA's
Emergency Response Standard which requires every em-
ployer to supply employees with information on proper ac-
tions during an emergency, where emergency equipment is
located, how to use it and a location outside of the building
where employees will meet after evacuating.272 Secondly,
OSHA's Hazard Communication Standard requires employ-
ers to develop a written program which lists all hazardous
chemicals used in the medical facility, their physical and
chemical ingredients, where they are used, the type of hazard
associated with their use, and other related information in-
cluding the name, address and telephone number of a respon-
sible party who can provide information and emergency
procedures for the hazardous chemical. 273 OSHA's Chemical
Hygiene Standard requires employers to establish written
policies for procedures, equipment, personal protective equip-
ment and work practices which will effectively protect em-
federal program. After the state has accomplished these steps and has operated
its program at a fully effective level for at least one year, federal enforcement
activity will cease in those areas over which the state has jurisdiction. Id. See
also State Participation, O.S.H. Rep. (BNA) No. 15, at 81:1001 (Jan. 30, 1986)
and see e.g., Los Alamitos Has Introduced A Bloodborne Pathogens Exposure
Control Plan, MED. WASTE NEWS, No. 12 (Mar. 17, 1993), reporting an example
of state OSHA implementation of a federal OSHA requirement.
272. 29 C.F.R. § 1910.38 (1981). OSHA has also promulgated a requirement
for a Hazardous Waste Emergency Response Plan, 29 C.F.R. § 1910.120 (1989)
applicable to clean-ups required by regulatory agencies, corrective actions, vol-
untary clean-ups recognized by regulatory authorities, operations involving
hazardous wastes at treatment, storage and disposal facilities, and emergency
response operations for the release or threatened release of hazardous sub-
stances. The Hazardous Waste Emergency Response Plan requirement ad-
dresses "hazardous substances" which are defined to include "any biological
agent and other disease-causing agent which after release into the environment
and upon exposure, ingestion, inhalation, or assimilation into any person...
may reasonably be anticipated to cause death, disease, behavioral abnormali-
ties, etc." 29 C.F.R. § 1910.120(a)(3)(B) (1989). Infectious substances conceiva-
bly fall within this definition of hazardous substances, thereby subjecting
employers undertaking one of the specified actions to the Hazardous Waste
Emergency Plan requirement.
273. 29 C.F.R. § 1910.1200 (1983) and revised 52 Fed. Reg. 31,877 (1987).
See also NIOSH, CRITERIA FOR A RECOMMENDED STANDARD: AN IDENTIFICATION
SYSTEM FOR OCCUPATIONALLY HAZARDOUs MATERIALS, (1974).
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ployees from hazardous chemicals in their facilities. 274 The
standard also requires documentation of medical treatment
for exposure, disposal of chemicals, procurement, distribution
and storage of chemicals and an employee training plan.275
Finally, OSHA recently promulgated a Bloodborne Pathogen
Rule requiring employers to protect workers from exposure to
bloodborne pathogens.276 The rule applies to all persons oc-
cupationally exposed to blood and other potentially infectious
materials and extends to workers who handle medical waste
that is put in red bags and physicians who are employed by a
corporation.277 Thus, this rule may become a consideration
in selecting a medical waste disposal option.278 Naturally,
costs are expected to rise as a result of the rule. The waste
management industry estimates compliance will cost it ap-
proximately $1,900,000, while compliance will cost hospitals
around $321,000,000.279
Passage of the Bloodborne Pathogen Rule evidences
OSHA's concern that "employees face a significant health
risk as a result of occupational exposure to blood and other
potentially infectious materials because they may contain
bloodborne pathogens."280 The Bloodborne Pathogen Rule re-
quires the employer to provide an exposure control plan,
training classes, preventive measures (including hepatitis B
vaccinations), use of CDC universal precautions, provision of
protective equipment, housekeeping programs, and records of
exposure incidents. 281 The OSHA standard for bloodborne
pathogens was adopted because exposed employees may face
274. 29 C.F.R. § 1910.1450 (1990).
275. Id.
276. 29 C.F.R. § 1910.1030a (1992). In addition, the Department of Labor
and Department of Health and Human Services published a Joint Advisory No-
tice, October 19, 1987, Protection Against Occupational Exposure to Hepatitis B
Virus and Human Immunodeficiency Virus, which discusses engineering con-
trols and work practices.
277. 29 C.F.R. § 1910.1030 (1992).
278. The Bloodborne Pathogen Rule was recently upheld against a challenge
by the American Dental Association. American Dental Assoc. v. Martin, 984
F.2d 823 (7th Cir. 1993).
279. WASTE AGE, supra note 6, at 68.
280. 56 Fed. Reg. 64,004 (1991).
281. 29 C.F.R. § 1910.1030 (1991).
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significant health risks, including death.28 2 The Bloodborne
Pathogen Rule is drafted so that employees in every state will
be protected by general, performance-oriented standards. To
the extent that state or regional differences exist, states with
occupational safety and health plans approved under Section
18 of the Occupational Safety and Health Act will be able to
develop their own standards to deal with any special
problems. 283 Compliance with applicable standards is
mandatory.
B. Department of Transportation Regulations
Transportation of hazardous materials is addressed by
the Hazardous Materials Transportation Act of 1974 (HMTA)
and the Hazardous Materials Transportation Uniform Safety
Act of 1990 (HMTUSA).284 The HMTA does not define haz-
ardous material, but instead gives this authority to the Secre-
tary of the Department of Transportation. In the Act,
Congress preempted any state law, regulation, order, ruling
or provision which is not substantively the same as the HM-
TUSA.28 5 DOT has held several state requirements regard-
282. "Hepatitis B virus.., has long been recognized as a pathogen capable of
causing serious illness and death. .. . The human immunodeficiency virus
(HIV), the virus that causes AIDS, has only been recognized in the last dec-
ade .... The consequences of HIV infection are grave, however, because HIV
causes the fatal disease AIDS." 56 Fed. Reg. 64,006 (1991).
283. Id. at 64,004. OSHA specifically recommends that hospitals comply
with state and local regulations when developing an infectious waste treatment
plan. Each plan should provide for: (1) designation of the waste that should be
managed as infectious, (2) segregation of infectious waste from noninfectious
waste, (3) packaging, (4) storage, (5) treatment, (6) disposal, (7) contingency
measures for emergency situations and (8) staff training. U.S. Dep't of Health
and Human Services, GuIDELINES FOR PROTECTING THE SAFETY AND HEALTH OF
HEALTH CARE WORKERS 6-1 (1988), [hereinafter NIOSH GUIDELINES].
284. Hazardous Materials Transportation Act (HMTA), 49 U.S.C. §§ 1801-
1812 (1983 & Supp. 1992), and Hazardous Materials Transportation Uniform
Safety Act (HMTUSA), 49 U.S.C. §§ 1801-1819 (1988).
285. 49 U.S.C. § 1804 (Supp. 1991) sets forth regulations governing trans-
portation of hazardous materials and expressly preempts any requirement of a
state, political subdivision or Indian tribe which is inconsistent with any re-
quirement of the Act or DOT Hazardous Material Regulations (HMRs). The
preemption is extensive and includes: (1) designation, description, classifica-
tion of hazardous materials; (2) packaging, handling, labeling, marking and
placarding of hazardous materials; (3) shipping documents; (4) written notifica-
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ing the definition and shipment of hazardous materials to be
inconsistent with DOT requirements and, therefore, pre-
empted.28 6 In deciding whether a state regulation is consis-
tent, DOT considers two factors: (1) whether compliance with
both the state requirement and the HMTA or the HMR is pos-
sible, and (2) the extent to which the state requirement is an
obstacle to the accomplishment and execution of the HMTA
and the HMR.28 7 By using this preemption doctrine, DOT en-
sures national uniformity during transportation of materials
which are regulated as hazardous. These standards are often
devised and monitored by DOT's Research and Special Pro-
grams Administration (RSPA). If the RSPA decides to add its
own definition of infectious substance or etiologic agent to the
list of hazardous materials, it is possible that transportation
of medical waste will also be federally preempted.
Recent rulemaking indicates preemption of medical
waste may become a reality in the near future. The effective
date of the RSPA final rule amending the Hazardous Mate-
rial Regulations (HMRs), with respect to infectious sub-
stances, has been delayed until October 1, 1994 to consider
unresolved issues raised in comments, petitions for reconsid-
eration, and exemption applications. 2 8 The final rule, pub-
lished in January 1991, adopted a revised definition of
"etiologic agent," removed the existing 50 milliliter exception
from regulation of etiologic agents, and clarified quantity lim-
itations for etiologic agents transported aboard aircraft.28 9
The new regulations apply to any facility that ships regulated
medical waste, any company that hauls it, and any maker of
packaging for regulated medical waste. The new RSPA rule
tion, recording and reporting of unintentional releases of hazardous materials;
and (5) design, marking, testing, etc. of packages used to transport hazardous
materials. Id. at § 1804(a)(4)(A)-(B).
286. See, e.g. Appeal of Inconsistency Ruling No. IR-31, State of Louisiana,
Statutes and Regulations on Hazardous Materials, 55 Fed. Reg. 36,735 (1990)
where the Research and Special Programs Administration (RSPA) found that
state regulations authorizing the designation of hazardous materials other than
those designated in the HMRs were preempted and unenforceable.
287. See 49 C.F.R.§ 107.209(C) 1992.
288. 58 Fed. Reg. 66,302 (1993). See also, 56 Fed. Reg. 197 (1991), 58 Fed.
Reg. 12,207 (1993).
289. 58 Fed. Reg. 12,207 (1993).
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adopts the MWTA definition of "regulated medical waste" to
distinguish between all medical waste and medical waste
containing an infectious substance. The rule also specifies
packaging requirements for regulated medical waste consis-
tent with those in the expired MWTA regulations. The RSPA
has thus created a subcategory of infectious substances-
those that are contained in or constitute medical waste. If an
infectious substance is being transported then it must be la-
beled, packaged and transported according to the HMRs. For
example, the new rules require all packaging containing in-
fectious substances to be marked "regulated medical waste."
It must also bear DOT's "infectious substance label," a set of
clearly marked identification numbers, and be accompanied
by special shipping papers. If the infectious substance is also
medical waste or is contained in medical waste, then the
shipper may use less rigorous packaging requirements that
are applicable to regulated medical waste. According to the
RSPA, if it had not provided some distinction between infec-
tious substances and regulated medical waste, all infectious
substances, regardless of how they were generated, would be
subject to the full extent of regulation.290 The cost of this
compliance, industry claimed, would be exorbitant. 291
In response to comments and petitions for reconsidera-
tion, the RSPA acknowledged that the HMRs potentially
overlap with other federal regulations governing infectious
substances, such as OSHA's Bloodborne Pathogen Rule and
CDC standards. Both require special packaging and labeling
for infectious substances and etiologic agents which differ
from the requirements of the HMRs.292 Critics say that fed-
290. Id. at 12,209-10 and 56 Fed. Reg. 66,142 (1991) wherein the RSPA re-
vised regulations at 49 C.F.R. § 173.197 (1991) to specify less rigorous require-
ments for infectious substances that are "regulated medical wastes."
291. DOT Packaging Rule Draws Concern from Medical Waste Industry,
WASTE AGE, Mar. 1992, at 8.
292. See e.g., 42 C.F.R. § 72 (1992), identifying CDC's requirements for the
transportation of etiologic agents in interstate traffic. These regulations specify
that they "are in addition to and not in lieu of any other packaging or other
requirements for the transportation of etiologic agents in interstate transporta-
tion prescribed by the Department of Transportation and other agencies of the
Federal Government." Id. at n.1. CDC's regulations set forth packaging and
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eral agencies are unnecessarily duplicating each other's re-
quirements; for example, DOT's black-on-white "infectious
substance" label conveys the same information as OSHA's or-
ange "biohazard" label.293 In short, each agency requires one
or more different labels on packages containing medical or in-
fectious waste. Complicating this scheme is the fact that the
RSPA attempts to align United States standards with those
of the United Nations Recommendations on the Transport of
Dangerous Goods. 294 The RSPA is currently evaluating an-
swers to its extensive request for comments; in particular, it
is concerned with comments addressing the potential overlap
or inconsistency between the new DOT standards and other
federal regulations governing infectious substances including
those issued by OSHA, CDC, the Food and Drug Administra-
tion, and the United States Postal Service. 295
labeling requirements for the transportation of materials containing etiologic
agents:
No person may knowingly transport or cause to be transported in
interstate traffic, directly or indirectly, any material including, but
not limited to, diagnostic specimens and biological products which
such person reasonably believes may contain an etiologic agent un-
less such material is packaged to withstand leakage of contents,
shocks, pressure changes, and other conditions incident to ordinary
handling in transportation.
Id. at § 72.2.
293. See Karen Pallarito, New Packing, Shipping Rules May Be Shelved,
MODERN HEALTHcARE, Sept. 28, 1992, at 33-34.
294. Interview with Eileen Martin, Regulatory Advisor, RSPA, Department
of Transportation, July 1993.
295. 56 Fed. Reg. 12,207, 12,210 (1993). Since the new rule would officially
add regulated medical wastes to the hazardous materials table, the medical
waste hauling industry is concerned with the rule's ramifications. See DOT
Packaging Rule Draws Concern from Medical Waste Industry, WASTE AGE, Mar.
1992, at 8, and Renee Blankenau, Medical Waste Transport Issues Aired, J. OF
AMER. Hosp. Assoc., Apr. 20, 1993, at 12. One hygienist at the American Hos-
pital Association observed that the amount of waste affected by the new RSPA
rule will depend on how individual hospitals interpret the definitions of regu-
lated medical waste and infectious substance. He estimated that the new rule
"would increase waste haulers' costs 12 to 18 cents per pound, which would
most likely be passed on to hospitals." Pallarito, supra note 293, at 34.
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C. U.S. Postal Service Regulations
Concern about exposure of postal workers to contami-
nated sharps being shipped in the United States mail led to
new regulations on the mailability of sharps and other medi-
cal devices. 296 Effective June 30, 1992, the regulations re-
quire that "used sharps and other used medical devices be
sent as First-Class or Priority Mail." 297 The Postal Service
also requires that used sharps be packaged in a securely
sealed primary container that is leak and puncture resistant
and has passed a vibration test. The package must also have
a secondary containment system, and both containers must
be enclosed in a specific type of shipping container which in-
cludes absorbent material. To ensure compliance with the
detailed standards, all distributors and manufacturers of
sharps containers are required to obtain authorization from
the United States Postal Service in order to transport their
products through the mail. To obtain authorization, all pack-
aging must have been "type-tested" and certified by an in-
dependent company. In addition, a bond is required to
ensure financial responsibility. 298 The Postal Service states
that the "bond is essential to avoid or minimize the expenses
incurred for containing and cleaning up spills and leaks that
occur on postal property, in addition to disposing of regulated
medical waste addressed for delivery at closed disposal
sites."299 Other medical devices that do not contain sharps
must be packaged in a securely sealed, leak resistant primary
container, which is then enclosed in a shipping container sim-
ilar to those used for mailing sharps.
The Postal Service received only 17 comments in re-
sponse to the proposed rule.300 Those organizations objecting
to the rule were concerned about the cost of complying with
the labeling, manifest, and testing requirements, and chal-
lenged the need for a bond.30 1 The regulation has its own def-
296. 57 Fed. Reg. 29,028 (1992) (to be codified at 39 C.F.R. pt. 111).
297. Id.
298. Id.
299. Id.
300. Id. The proposed rule is at 57 Fed. Reg. 9404 (1992).
301. 57 Fed. Reg. 29,028 (1992).
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inition of terms such as "sharps," "medical devices," and
"infectious substance" which the regulated community must
reconcile with other, sometimes conflicting definitions
promulgated by other regulatory agencies.
D. EPA Guidelines
The Resource Conservation and Recovery Act of 1976
(RCRA), as amended, requires EPA to develop and evaluate
environmentally sound methods for solid waste management,
and to provide information, research and financial assistance
to states.30 2 Congress intended RCRA to provide for the pro-
mulgation of guidelines for solid waste collection, transport,
separation, recovery and disposal practices, and a "cradle-to-
grave" management system for solid wastes identified as haz-
ardous.30 3 In fulfilling this charter, EPA has published haz-
ardous waste regulations, but has chosen not to include
infectious waste under the hazardous waste definition be-
cause the agency believes "considerable evidence that these
wastes cause harm to human health and the environment is
needed to support [flederal rulemaking."3 0 4 Instead, in re-
sponse to numerous requests for technical information and
guidance on infectious waste management, EPA published its
findings regarding infectious waste management techniques
in September 1982 as a guidance manual, the Draft Manual
for Infectious Waste Management. After receiving and consid-
ering comments, the agency decided to revise the manual and
issued the EPA Guide for Infectious Waste Management in
May 1986. Since the expiration of the MWTA, this EPA
guide represents the agency's current perspective on accepta-
ble infectious waste management practices. In summary, it
addresses infectious waste characterization, infectious waste
management, treatment of infectious wastes, and recommen-
dations for development of an infectious waste management
plan.30 5 It is designed to guide those persons responsible for
managing infectious waste at facilities such as hospitals, lab-
302. 42 U.S.C. § 6902(a) (1988).
303. Id.
304. EPA GUME, supra note 30, at vi.
305. Id.
62http://digitalcommons.pace.edu/pelr/vol11/iss2/2
REGULATION OF MEDICAL WASTE
oratories, animal experimentation units, industrial plants,
biotechnology companies, and others which generate infec-
tious wastes. 30 6
One of the most significant aspects of the guide is EPA's
definition of infectious waste as waste capable of producing
an infectious disease, taking into account four factors: (1)
presence of a pathogen of sufficient virulence, (2) dose, (3)
portal of entry, and (4) resistance of the host. The guide's def-
inition has been adopted by many states and agencies regu-
lating medical waste; however, it is nonbinding at the federal
level.30 7 EPA "strongly" suggests that agencies use its guide
only as reference material. 308
The guide has been criticized on two grounds. First, be-
cause EPA was uncertain of the health risks posed by infec-
tious wastes, it failed to set forth a minimum national
standard for the management and disposal of infectious
waste. 30 9 Because EPA wrote the guide for persons manag-
ing infectious waste treatment for private facilities, not for
state and local agencies, it provided only suggested compo-
nents of an infectious waste management plan and failed to
recommend how the states should enforce their policies. 310
One author has observed that the guide thus technically sat-
isfies RCRA's objective of providing information, but it may
have added to the confusion surrounding the risk associated
with infectious waste by not providing a basis for interstate
control.311 In addition, EPA's original position, that regula-
tion of infectious waste is premature and unnecessary until
its risks are proven, seems contradictory to the guide's sug-
gestions for private management and state regulation.31 2 It
is possible that the findings EPA releases in its final report to
Congress under the MWTA will clarify these issues.
306. Id. at 1-1.
307. Id. See OTA REPORT, supra note 3, at 3 for a comparison of the compo-
nents of EPA's definition and the CDC's definition.
308. EPA GUIDE, supra note 30, at 1-1.
309. Goldie, supra note 174, at 132.
310. Goldie, supra note 174, at 148 n.125. See also THE COUNCIL OF STATE
GOVERNMENTS, STATE INFECTIOUS WASTE REGULATORY PRoGRAMs 4 (1988).
311. Goldie, supra note 174, at 156.
312. Id. at 157.
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E. Centers for Disease Control Guidelines
Like EPA, the Centers for Disease Control (CDC) of the
U. S. Public Health Service has issued guidelines addressing
certain aspects of infectious waste. CDC is a federal public
health agency charged with the surveillance and investiga-
tion of infectious diseases in hospitals.313 CDC collects
weekly, monthly and yearly statistics on many infectious dis-
eases and on control programs for health care facilities. The
Agency also makes recommendations necessary for disease
control. 314
CDC has most directly addressed medical waste in two
publications: "Recommendations for Prevention of HIV
Transmission in Health Care Settings,"315 and "Guidance for
Handwashing and Hospital Environmental Control."316 The
1987 "Recommendations" suggested that "universal precau-
tions" relating to blood and body fluid be consistently used for
all patients regardless of their bloodborne infection. 317 Thus,
blood and certain body fluids of all patients were considered
potentially infectious for HIV, hepatitis B and other blood-
borne pathogens. In response to numerous questions about
the universal precautions, the CDC updated its "Recommen-
dations" in 1988.318 These "precautions" apply primarily to
health care workers and medical institutions; consequently,
the guidelines reach the generators of infectious waste and
their on-site handling and treatment, and have not had as
much impact as the EPA guidelines on medical waste re-
313. NIOSH Guidelines, supra note 283, at 2-21.
314. Id.
315. The Center for Disease Control, Recommendations for Prevention of
HIV Transmission in Health Care Settings, MORBIDITY & MORTALITY WEEKLY
REP. (Supp.), Vol. 36 (Aug. 21, 1987) [hereinafter Recommendations].
316. Center for Disease Control, CDC Guidelines for the Prevention and Con-
trol of Nosocomial Infections: Guideline for Handwashing and Hospital Envi-
ronmental Control (1985) [hereinafter Handwashing Guidelines].
317. Recommendations, supra note 315.
318. Center for Disease Control, Update: Universal Precautions for Preven-
tion of Transmission of Human Immunodeficiency Virus, Hepatitis B Virus, and
Other Bloodborne Pathogens in Health Care Settings, MORBIDrry & MORTALITY
WEEKLY REP., Vol. 37 (June 24, 1988). The CDC now limits the application of
universal precautions to blood and other body fluids containing visible blood,
and to semen and other specified body fluids. Id.
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moval and disposal. 319 One commentator posits that CDC's
1987 "Recommendations" quelled the urgency of labeling
most medical waste as infectious because the CDC chose to
recommend classifying waste material based on its risk of
disease transmission.320 Indeed, the "Recommendations"
state that identifying wastes which require special precau-
tions is a matter of judging the relative risk of disease trans-
mission. While any item that has contact with blood or body
fluids may be potentially infective, it is not usually consid-
ered practical or necessary to treat all such waste as infec-
tive. 321 A hospital's calculation of its total amount of
infectious waste can vary vastly, depending on whether it
uses CDC or EPA definitions of infectious waste. As dis-
cussed, determining which portion of medical waste is infec-
tious goes to the heart of the definitional problem associated
with medical waste management. 322 Thus, until CDC and
EPA can reach consensus on the definition of infectious
waste, generators may continue to be confused regarding
proper classification and management of medical wastes.
The purpose of the CDC "Handwashing Guidelines" is to
disseminate advice on how to prevent or control specific infec-
tions acquired while in the hospital, called "nosocomial infec-
tions."3 23 The guidelines offer recommendations regarding
handwashing techniques, handwashing with antimicrobial
products, cleaning, disinfecting and sterilizing patient-care
equipment, and handling infective waste. According to the
guidelines, handwashing is the single most important proce-
dure for preventing hospital-acquired infections.3 24
319. Goldie, supra note 174, at 143.
320. Goldie, supra note 174, at 143. Goldie maintains that this CDC policy
for treatment of infectious waste may have convinced EPA that insufficient evi-
dence of risk existed. In reality, "CDC's recommendation to EPA did not mean
infectious waste is not hazardous, only that not all hospital waste should be
classified as infectious." EPA may have misinterpreted this recommendation
when it made its decision not to regulate infectious waste disposal. Id. at 144.
321. Recommendations, supra note 315.
322. See discussion in Chapter 1.
323. Handwashing Guidelines, supra note 316.
324. Id.
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F. Joint Commission on Accreditation of Healthcare
Organizations Standards
The Joint Commission on Accreditation of Healthcare
Organizations (JCAHO), formerly the Joint Commission on
Accreditation of Hospitals, accredits health care organiza-
tions and reevaluates the accreditation every 3 years.
JCAHO conducts inspections and requires hospitals to estab-
lish policies and procedures for monitoring and responding to
safety and health hazards. 325 In its manual, JCAHO
designates infectious wastes and sharps as hazardous wastes
along with chemical, chemotherapeutic and radioactive
wastes.326 The manual outlines methods for handling each
type of waste and requires a system to handle all such wastes
that complies with Federal, State and local regulations. 327
JCAHO has recognized that hospitals must manage their
hazardous materials and infectious waste from point of origin
to final disposal. 32s Under its accreditation standard, a hos-
pital's infectious waste management program must, among
other things:
(1) control the waste from its point of origin to its final dis-
posal; (2) protect patients, personnel, visitors and the envi-
ronment; (3) include policies and procedures for identifying
and managing hazardous materials and waste, including
the substitution of less hazardous agents, process changes,
isolation, and ventilation; (4) review operational policies
and procedures at least annually by the respective safety
or control committees, with recommendations, conclusions,
and actions referred to those persons responsible for the
hospital's quality assurance program; (5) provide job train-
ing to its waste handlers .... 329
325. JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS,
ACCREDITATION MANUAL FOR HOSPITALS (1990).
326. Id.
327. Id. If federal regulations do not exist, the hospital must comply with
state and local regulations and if these do not exist then hospitals should com-
ply with either CDC or EPA guidelines. OTA BACKGROUND PAPER, supra note 2,
at 7 n.18.
328. JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS,
ACCREDITATION MANUAL FOR HOSPITALS (1990).
329. Infectious Medical Wastes, JAMA, supra note 52 at 1670-71.
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Obtaining JCAHO accreditation is critical for most hos-
pitals. Therefore, even though the organization's recommen-
dations and policies are not legally binding or enforceable,
they can have significant effect on hospital operation and
procedure.
VIII. Conclusion
The putative risks to public health and the environment
posed by the mismanagement of medical waste have not been
adequately demonstrated to warrant federal regulation of
this waste stream to the extent it was under the MWTA. To
treat all medical waste as hazardous without substantive evi-
dence that it indeed presents a viable threat will produce un-
necessary costs for medical waste managers and, ultimately,
for health care patients. Stringent RCRA Subtitle C require-
ments should be reserved for medical waste that can be iden-
tified as truly infectious and which has a proven capacity to
inflict substantial harm upon the public or the environment.
In order to identify such waste, EPA needs to devise a uni-
form objective test for infectious waste that can be used by
health care organizations and other medical waste generators
in their waste management. Such a test is the necessary first
step toward developing a uniform definition of infectious
waste which is, in turn, an absolute necessity for consistent
regulation. Without a scientifically based, national definition
of infectious medical waste, an inconsistent, inequitable
scheme of regulation is likely to prevail. Therefore, federal
intervention to this extent alone is needed. EPA already has
authority under RCRA to regulate Subtitle C and Subtitle D
wastes. The Agency could most appropriately address this is-
sue and maintain flexibility by promulgating regulations
which address several areas of confusion. For instance, EPA
should define and distinguish medical waste and infectious
waste, and clarify when infectious waste meets the character-
istics of hazardous waste as defined in 42 U.S.C. § 6903. In-
sofar as possible, EPA should consult with others such as
CDC and JCAHO, in order to reconcile definitional and policy
differences and to attempt to issue compatible, uniform gui-
dance. Or, EPA could simply defer to CDC's definition and
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cross-reference it in its regulations. Likewise, OSHA and
DOT should bring their definitions and policies concerning
infectious waste into concert with EPA and CDC so that gen-
erators, employers and transporters are complying with a co-
herent, predictable scheme of regulation instead of a
conflicting panoply of requirements.
In order to achieve nationally cohesive regulation of med-
ical waste, EPA needs to take the lead. First, it must issue
its overdue MWTA report to Congress, which purportedly ex-
plores further the risks of infectious waste. Then, EPA
should sponsor or encourage more intensive study of the
safety and efficiency of various treatment and disposal meth-
ods of infectious waste, particularly incineration, land dispo-
sal, disposal via the sanitary sewer system and alternative
technologies. The existing studies of medical waste treat-
ment and disposal do not adequately examine the toxic per-
sistence of agents such as the HIV virus or its mutagenicity
in different disposal environments over a long-term period.
Finally, EPA needs to recommend to the states appropri-
ate methods of handling and treating medical waste. The
Agency should also provide guidance on cogent ways states
can enforce their own medical waste regulatory programs, in-
cluding home health care medical waste management. To ac-
complish this the Agency could issue more current special
guidelines.
Since the passage of the MWTA in 1988 and its expira-
tion in 1991, states and localities have aggressively regulated
the medical waste stream. In the absence of clear federal gui-
dance as to what constitutes infectious medical waste, and
when or whether it should be treated as solid or hazardous
waste, states have promulgated a diverse array of laws and
regulations. The disparity among states' regulation of medi-
cal waste often causes inequitable or conflicting treatment of
waste at different levels and complicates interstate waste
shipment. Although states have demonstrated in recent
years that they are the most suitable regulators of this waste
stream, federal guidance and some regulation, perhaps via
state-delegated RCRA programs, are essential to effective
medical waste management.
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Even though the alarming beach wash-ups which precip-
itated medical waste regulation have long passed, the current
national preoccupation with AIDS infection and rising health
care costs provide another opportunity to consider the medi-
cal waste stream. Medical waste management often consti-
tutes a hidden cost of health care, and some of these costs
may be attributed to irregularities in its regulation. Our na-
tional interest would best be served by a more unified, sci-
ence-based medical waste management policy.
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